8520 POSTER Podoplanin Regulates the Proliferation of Oral Squamous Cell Carcinoma Cells via Its Binding to Extracellular Matrix (Englisch)
- Neue Suche nach: Tsuneki, M.
- Neue Suche nach: Maruyama, S.
- Neue Suche nach: Yamazaki, M.
- Neue Suche nach: Cheng, J.
- Neue Suche nach: Saku, T.
- Neue Suche nach: Tsuneki, M.
- Neue Suche nach: Maruyama, S.
- Neue Suche nach: Yamazaki, M.
- Neue Suche nach: Cheng, J.
- Neue Suche nach: Saku, T.
In:
EUROPEAN JOURNAL OF CANCER
;
47
;
S550
;
2011
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:8520 POSTER Podoplanin Regulates the Proliferation of Oral Squamous Cell Carcinoma Cells via Its Binding to Extracellular Matrix
-
Beteiligte:Tsuneki, M. ( Autor:in ) / Maruyama, S. ( Autor:in ) / Yamazaki, M. ( Autor:in ) / Cheng, J. ( Autor:in ) / Saku, T. ( Autor:in )
-
Erschienen in:EUROPEAN JOURNAL OF CANCER ; 47 ; S550
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam.
-
Erscheinungsdatum:01.01.2011
-
Format / Umfang:S550
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.994
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.994 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 47
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1
-
New therapeutic avenues in lung cancer based on disturbances in PI3K and RAS pathwaysRosell, R. et al. | 2011
- 1
-
The requirements of a specialist Prostate Cancer Unit: A discussion paper from the European School of OncologyValdagni, R. / Albers, P. / Bangma, C. / Drudge-Coates, L. / Magnani, T. / Moynihan, C. / Parker, C. / Redmond, K. / Sternberg, C. N. / Denis, L. et al. | 2011
- 1
-
Adjuvant Systemic Treatment for Women with Breast Cancer: The Future of Clinical TrialsGoldhirsch, A. / Gelber, R. et al. | 2011
- 2
-
Synchronous Chemo-radiation Can Reduce Local Recurrence in Early Stage Breast Cancer: Results of the SECRAB Trial (ISRCTN: 84214355) Presented on Behalf of the SECRAB Steering CommitteeFernando, I. / Bowden, S. J. / Brookes, C. L. / Grieve, R. / Spooner, D. / Agrawal, R. K. / Brunt, A. M. / Churn, M. / Rea, D. W. / Canney, P. et al. | 2011
- 2
-
VANTAGE 014: Vorinostat (V) in Patients With Advanced Malignant Pleural Mesothelioma (MPM) who Have Failed Prior Pemetrexed and Either Cisplatin or Carboplatin Therapy: A Phase III, Randomized, Double-Blind, Placebo-Controlled TrialKrug, L. M. / Kindler, H. / Calvert, H. / Manegold, C. / Tsao, A. S. / Fennell, D. / Lubiniecki, G. M. / Sun, X. / Smith, M. / Baas, P. et al. | 2011
- 2
-
A Pivotal Multicenter Trial Evaluating Efficacy and Safety of the Hedgehog Pathway Inhibitor (HPI) Vismodegib in Patients With Advanced Basal Cell Carcinoma (BCC)Dirix, L. / Migden, M. R. / Oro, A. E. / Hauschild, A. / Lewis, K. / Mueller, A. B. / Yauch, R. / Reddy, J. C. / Sekulic, A. et al. | 2011
- 3
-
Overall Survival Benefit of Radium-223 Chloride (Alpharadin) in the Treatment of Patients with Symptomatic Bone Metastases in Castration-resistant Prostate Cancer (CRPC): a Phase III Randomized Trial (ALSYMPCA)Parker, C. / Heinrich, D. / OSullivan, J. M. / Fossa, S. / Chodacki, A. / Demkow, T. / Cross, A. / Bolstad, B. / Garcia-Vargas, J. / Sartor, O. et al. | 2011
- 3
-
Blood Pressure and Risk of Incident and Fatal Cancer in the Metabolic Syndrome and Cancer Project (Me-Can) - Analysis of Seven Prospective CohortsVan Hemelrijck, M. / Stocks, T. / Jonsson, H. / Manjer, J. / Ulmer, H. / Bjorge, T. / Stattin, P. et al. | 2011
- 4
-
Laparoscopic Surgery Versus Open Surgery for Rectal Cancer: Short-term Outcomes of a Randomised TrialBonjer, H. J. / Haglind, E. / Cuesta, M. A. / Furst, A. / Lacy, A. / van der Pas, M. H. / Hop, W. C. et al. | 2011
- 4
-
Everolimus in Subependymal Giant Cell Astrocytomas (SEGA) Associated with Tuberous Sclerosis Complex (TSC): Results of EXIST-1, a Double-Blind Placebo-controlled Phase III TrialBebin, M. / Franz, D. N. / Sahmoud, T. / Belousova, E. / Sparagana, S. / Frost, M. / Ford, J. / Shah, G. / Cauwel, H. / Jozwiak, S. et al. | 2011
- 4
-
Very Accelerated Radiotherapy (RT) Versus Concomitant Chemo-Radiotherapy (Ct-Rt) In Locally Advanced Head And Neck Cancer: Long Term Results From 2 Phases III GORTEC Randomized TrialsBourhis, J. / Sire, C. / Graff, P. / Gregoire, V. / Maingon, P. / Lapeyre, M. / Tortochaux, J. C. / Gery, B. / Martin, L. / Alfonsi, M. et al. | 2011
- 5
-
Results From VELOUR, a Phase 3 Study of Aflibercept (A) Versus Placebo (pbo) in Combination with FOLFIRI for the Treatment of Patients (pt) with Previously Treated Metastatic Colorectal Cancer (MCRC)Tabernero, J. / Van Cutsem, E. / Lakomy, R. / Prausova, J. / Ruff, P. / Van Hazel, G. / Moiseyenko, V. / Ferry, D. / McKendrick, J. / Soussan-Lazard, K. et al. | 2011
- 5
-
Efficacy in Patient Subgroups in OCEANS, a Randomized, Double-blinded, Placebo-controlled, Phase 3 Trial of Chemotherapy +- Bevacizumab in Patients with Platinum-sensitive Recurrent Epithelial Ovarian (OC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC)Aghajanian, C. / Blank, S. V. / Goff, B. / Judson, P. L. / Makhija, S. / Sharma, S. K. / Nycum, L. R. / Yi, J. / Husain, A. et al. | 2011
- 6
-
Delivering Affordable Cancer Care in High-income Countries: a Lancet Oncology CommissionSullivan, R. / Peppercorn, J. / Sikora, K. / Zalcberg, J. / Meropol, N. / Amir, E. / Khayat, D. / Boyle, P. / Tannock, I. / Fojo, T. et al. | 2011
- 6
-
A Multicentre Randomised Trial of Ibandronate Compared to Single Dose Radiotherapy for Localised Metastatic Bone Pain in Prostate Cancer (RIB)Hoskin, P. / Sundar, S. / Reczko, K. / Forsyth, S. / Mithal, N. / Sizer, B. / Toy, L. / Stratford, M. / Jitlal, M. et al. | 2011
- 6
-
Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO-2 Phase III TrialBaselqa, J. / Campone, M. / Sahmoud, T. / Piccart, M. / Burris, H. / Rugo, H. / Noguchi, S. / Gnant, M. / Mukhopadhyay, P. / Hortobagyi, G. et al. | 2011
- 7
-
Identification of Novel Somatic Mutations in SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts and Other Common CancersPapaemmanuil, E. / Malcovati, L. / Cazzola, M. / Hellstrom-Lindberg, E. / Bowen, D. / Boultwood, J. B. / Green, A. R. / Futreal, P. A. / Stratton, M. R. / Campbell, P. J. et al. | 2011
- 7
-
The EORTC 10041/BIG 03-04 MINDACT (Microarray in Node Negative and 1 to 3 Positive Lymph Node Disease May Avoid ChemoTherapy) Trial: Patients Baseline Characteristics and Logistics Aspects After a Successful AccrualPiccart, M. / Bogaerts, J. / Cardoso, F. / Werutsky, G. / Delaloge, S. / Van t Veer, L. / Rubio, I. / Moulin, C. / Engelen, K. / Viale, G. et al. | 2011
- 8
-
Cognitive and Cardiac Outcome After Prenatal Exposure to Chemotherapy in Children 18 Months or OlderAmant, F. / Van Calsteren, K. / Halaska, M. / Mhallem, M. / Lagae, L. / Willemsen, M. / Kapusta, L. / Van Calster, B. / Mertens, L. / Ottevanger, P. et al. | 2011
- 8
-
A Phase l/lI, Open-label, Randomised Study of BIBF 1120 Plus mFOLFOX6 Compared to Bevacizumab Plus mFOLFOX6 in Patients with Metastatic Colorectal CancerVan Cutsem, E. / Prenen, H. / Guillen-Ponce, C. / Bennouna, J. / Di Benedetto, M. / Bouche, O. / Staines, H. / OumHamed, Z. / Studeny, M. / Capdevila, J. et al. | 2011
- 8
-
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumoursAapro, M. S. / Bohlius, J. / Cameron, D. A. / Lago, L. D. / Donnelly, J. P. / Kearney, N. / Lyman, G. H. / Pettengell, R. / Tjan-Heijnen, V. C. / Walewski, J. et al. | 2011
- 8
-
Efficacy of Veliparib (ABT-888) Plus Temozolomide Versus Temozolomide Alone: a Randomized, Double-blind, Placebo-controlled Trial in Patients with Metastatic MelanomaMiddleton, M. / Friedlander, P. / Hamid, O. / Daud, A. / Plummer, R. / Schuster, R. / Qian, J. / Luo, Y. / Giranda, V. / McArthur, G. et al. | 2011
- 9
-
Reversal of Tamoxifen Resistance (Hormone Resistance) by Addition of Sirolimus (mTOR Inhibitor) in Metastatic Breast CancerBhattacharvva, G. S. / Biswas, J. / Singh, J. K. / Singh, M. / Govindbabu, K. / Ranade, A. A. / Malhotra, H. / Parikh, P. M. / Shahid, T. / Basu, S. et al. | 2011
- 9
-
Drugging the Undruggable Small-molecule Inhibition of Ras OncoproteinFang, G. / Maurer, T. / Garrenton, L. / Skelton, N. / Fauber, B. / Malek, S. / Giannetti, A. / Jackson, P. / Rudolph, J. / Wang, W. et al. | 2011
- 10
-
Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)Mehta, M. / Wang, M. / Aldape, K. / Sulman, E. / Stupp, R. / Jaeckle, K. / Blumenthal, D. / Erridge, S. / Curran, W. / Gilbert, M. et al. | 2011
- 10
-
A Double-blind, Randomized Phase lib Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared to Placebo (PL) When Administered in Combination with Docetaxel And/or Letrozole in Patients with Metastatic Breast Cancer (MBC): FM-B07-01 TrialMariani, G. / Burdaeva, O. / Roman, L. / Staroslawska, E. / Udovitsa, D. / Driol, P. / Goisis, G. / Zamagni, C. / Semiglazov, V. / Gianni, L. et al. | 2011
- 11
-
Escalated-dose Conformai Radiotherapy for Localised Prostate Cancer: Long-term Overall Survival Results From the MRC RT01 Randomised Controlled TrialDearnaley, D. P. / Jovic, G. / Syndikus, I. / Graham, J. D. / Aird, E. G. / Khoo, V. / Cowan, R. / Sydes, M. R. et al. | 2011
- 11
-
A Phase 2b, Double-Blind, Randomized Study Evaluating the Efficacy and Safety of Sorafenib (SOR) Compared With Placebo (PBO) When Administered in Combination With Chemotherapy (Modified FOLFOX6) for First-line Treatment (tx) of Patients (Pts) With Metastatic Colorectal Cancer (mCRC). The RESPECT TrialTabernero, J. / Garcia-Carbonero, R. / Konne, C. H. / ODwyer, P. J. / Sobrero, A. / Van Cutsem, E. / Gladkov, O. / Davidenko, I. / Salazar, R. / Cassidy, J. et al. | 2011
- 11
-
Celecoxib Plus Hormone Therapy Vs Hormone Therapy Alone for Hormone-sensitive Prostate Cancer: First Results From the STAMPEDE Randomised Controlled Trial (MRC PR08)James, N. D. / Svdes, M. R. / Mason, M. D. / Clarke, N. W. / Dearnaley, D. P. / Dwyer, J. / Jovic, G. / Russell, J. M. / Thalmann, G. / Parmar, M. K. et al. | 2011
- 12
-
Quality of Life Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: a Gynecologic Oncology Group StudyMonk, B. J. / Huang, H. / Burger, R. A. / Mannel, R. L. / Homesley, H. D. / Fowler, J. / Greer, B. E. / Boente, M. / Liang, S. X. / Wenzel, L. et al. | 2011
- 12
-
Quality of Life in the ICON7 GCIG Phase III Randomised Clinical TrialStark, D. / Nankivell, M. / Hilpert, F. / Elit, L. / Brown, J. / Lanceley, A. / Valikova, G. / Oza, A. / Swart, A. M. / Perren, T. et al. | 2011
- 12
-
Mutation and Protein Expression Biomarkers Correlate with Response to AKT Inhibition in a Phase I Trial of the Oral Pan AKT Inhibitor GSK2141795 (GSK795) in Patients (pts) with Platinum Resistant Ovarian CancerGunqor, H. / Stronach, E. / Curry, E. / Saleem, A. / Agarwal, R. / Blagden, S. / Babar, S. / Mills, G. / Morris, S. R. / Gabra, H. et al. | 2011
- 13
-
Results of a Pilot External Quality Assurance Scheme for Somatic EGFR Mutation Testing in Non-Small Cell Lung Cancer Managed by EMQN, ESMO, ESP, and ETOPNormanno, N. / Patton, S. / Murray, S. / Blackhall, F. / Kerr, K. M. / Dietel, M. / Filipits, M. / Taron, M. / Stahel, R. / Thunnissen, E. et al. | 2011
- 13
-
Safety and Efficacy of Panitumumab (pmab) in HPV Positive (+) and HPV Negative (-) Recurrent/metastatic (R/M) Squamous Cell Carcinoma of the Head and Neck (SCCHN): Analysis of the Phase 3 SPECTRUM TrialVermorken, J. / Stohlmacher, J. / Oliner, K. / Villanueva, C. / Foa, P. / Winquist, E. / Licitra, L. / Skladowski, K. / Pan, Z. / Bach, B. A. et al. | 2011
- 14
-
A Phase II Study of Sorafenlb In Patients with Locally Advanced And/or Metastatic (stage 1MB or IV) Non-small Cell Lung Cancer (NSCLC) with a K-Ras MutationDinqemans, A. M. / Mellema, W. W. / Groen, H. J. / van Wijk, A. / Burgers, S. / Kunst, P. W. / Thunnissen, F. B. / Heideman, D. A. / Smit, E. F. et al. | 2011
- 14
-
Vemurafenlb Improves Overall Survival Compared to Dacarbazlne In Advanced BRAFV600E-mutated Melanoma: Updated Survival Results From a Phase III Randomised, Open-label, Multlcentre TrialMcArthur, G. / Hauschild, A. / Robert, C. / Haanen, J. B. / Ascierto, P. / Lee, R. J. / Nolop, K. / Nelson, B. / Flaherty, K. T. / Chapman, P. B. et al. | 2011
- 14
-
Unrecognised and Underprepared: an Exploratory Mixed Method Study of Informal Carers Experiences of Supporting Someone Through ChemotherapyReam, E. / Pedersen, V. / Oakley, C. / Richardson, A. / Taylor, C. / Verity, R. et al. | 2011
- 15
-
Denosumab Treatment for Giant Cell Tumor of Bone (GCTB) in Adolescent Patients: Interim Results From a Phase II StudyEnqellau, J. / Chawla, S. / Grimer, R. / Powell, A. / Schuetze, S. / Skubitz, K. / Staddon, A. / Atchison, C. / Zhao, Y. / Jacobs, I. et al. | 2011
- 15
-
Response to Imatinib Rechallenge of GIST That Recurs Following Completion of Adjuvant Imatinib Treatment - the First Analysis in the SSGXVIII/AIO Trial Patient PopulationReichardt, P. / Hartmann, J. T. / Hall, K. S. / Eriksson, M. / Schutte, J. / Ramadori, G. / Hohenberger, P. / Duyster, J. / Leinonen, M. / Joensuu, H. et al. | 2011
- 15
-
A Randomized Clinical Trial of Adjuvant Chemotherapy with Doxorubicin, Ifosfamide, and Cisplatin in Localized Uterine Sarcomas. Results On 81 Randomized PatientsPautier, P. / Floquet, A. / Gladieff, L. / Berton-Rigaud, D. / Piperno-Neumann, S. / Selle, F. / Guillemet, C. / Weber, B. / Rey, A. et al. | 2011
- 16
-
Evaluation of Individual Codon 12 and 13 Mutant (MT) KRAS Alleles as Prognostic and Predictive Biomarkers of Response to Panitumumab (pmab) in Patients with Metastatic Colorectal Cancer (mCRC)Peeters, M. / Douillard, J. Y. / Van Cutsem, E. / Siena, S. / Zhang, K. / Williams, R. / Wiezorek, J. et al. | 2011
- 16
-
AVAPERL (MO22089): Final Efficacy Outcomes for Patients (pts) With Advanced Non-squamous Non-small Cell Lung Cancer (nsNSCLC) Randomised to Continuation Maintenance (mtc) with Bevacizumab (bev) or Bev + Pemetrexed (pern) After First-line (1L) Bev-cisplatin (cis)-pem Treatment (Tx)Barlesi, F. / de Castro, J. / Dvornichenko, V. / Kim, J. H. / Pazzola, A. / Rittmeyer, A. / Vikstrom, A. / Mitchell, L. / Wong, E. K. / Gorbunova, V. et al. | 2011
- 33
-
Molecular mechanisms of leptin and adiponectin in breast cancerJarde, T. / Perrier, S. / Vasson, M. P. / Caldefie-Chezet, F. et al. | 2011
- 44
-
p53 and autophagy in cancer: Guardian of the genome meets guardian of the proteomeRyan, K. M. et al. | 2011
- 51
-
The prevalence and burden of symptoms amongst cancer patients attending palliative care in two African countriesHarding, R. / Selman, L. / Agupio, G. / Dinat, N. / Downing, J. / Gwyther, L. / Mashao, T. / Mmoledi, K. / Sebuyira, L. M. / Ikin, B. et al. | 2011
- 57
-
Quality of pathology reports for advanced ovarian cancer: Are we missing essential information?:An audit of 479 pathology reports from the EORTC-GCG 55971/NCIC-CTG OV13 neoadjuvant trialVerleye, L. / Ottevanger, P. B. / Kristensen, G. B. / Ehlen, T. / Johnson, N. / van der Burg, M. E. / Reed, N. S. / Verheijen, R. H. / Gaarenstroom, K. N. / Mosgaard, B. et al. | 2011
- 65
-
The acute skin and heart toxicity of a concurrent association of trastuzumab and locoregional breast radiotherapy including internal mammary chain: A single-institution studyCaussa, L. / Kirova, Y. M. / Gault, N. / Pierga, J. Y. / Savignoni, A. / Campana, F. / Dendale, R. / Fourquet, A. / Bollet, M. A. et al. | 2011
- 74
-
Safety of pregnancy following breast cancer diagnosis: A meta-analysis of 14 studiesAzim, H. A. / Santoro, L. / Pavlidis, N. / Gelber, S. / Kroman, N. / Azim, H. / Peccatori, F. A. et al. | 2011
- 84
-
High-dose cyclophosphamide-irinotecan-vincristine for primary refractory neuroblastomaKushner, B. H. / Kramer, K. / Modak, S. / Yataghene, K. / Cheung, N. K. et al. | 2011
- 90
-
Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Groupvon Stackelberg, A. / Volzke, E. / Kuhl, J. S. / Seeger, K. / Schrauder, A. / Escherich, G. / Henze, G. / Tallen, G. et al. | 2011
- 98
-
Clustering of concordant and discordant cancer types in Swedish couples is rareWeires, M. / Bermejo, J. L. / Sundquist, J. / Hemminki, K. et al. | 2011
- 107
-
Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanomaWang, L. E. / Huang, Y. j. / Yin, M. / Gershenwald, J. E. / Prieto, V. G. / Lee, J. E. / Duvic, M. / Grimm, E. A. / Wei, Q. et al. | 2011
- 116
-
Association between Epstein-Barr virus infection and risk for development of pregnancy-associated breast cancer: Joint effect with vitamin D?Agborsangaya, C. B. / Lehtinen, T. / Toriola, A. T. / Pukkala, E. / Surcel, H. M. / Tedeschi, R. / Lehtinen, M. et al. | 2011
- 121
-
Four and a half LIM protein 2 (FHL2) negatively regulates the transcription of E-cadherin through interaction with Snail1Zhang, W. / Wang, J. / Zou, B. / Sardet, C. / Li, J. / Lam, C. S. / Ng, L. / Pang, R. / Hung, I. F. / Tan, V. P. et al. | 2011
- 131
-
Diagnostic and prognostic role of plasma levels of two forms of cytokeratin 18 in patients with non-small-cell lung cancerDe Petris, L. / Branden, E. / Herrmann, R. / Sanchez, B. C. / Koyi, H. / Linderholm, B. / Lewensohn, R. / Linder, S. / Lehtio, J. et al. | 2011
- 138
-
Down-regulation of the miRNA master regulators Drosha and Dicer is associated with specific subgroups of breast cancerDedes, K. J. / Natrajan, R. / Lambros, M. B. / Geyer, F. C. / Lopez-Garcia, M. A. / Savage, K. / Jones, R. L. / Reis-Filho, J. S. et al. | 2011
- 151
-
MexTAg mice exposed to asbestos develop cancer that faithfully replicates key features of the pathogenesis of human mesotheliomaRobinson, C. / Walsh, A. / Larma, I. / O'Halloran, S. / Nowak, A. K. / Lake, R. A. et al. | 2011
- 163
-
MicroRNA regulation of core apoptosis pathways in cancerLima, R. T. / Busacca, S. / Almeida, G. M. / Gaudino, G. / Fennell, D. A. / Vasconcelos, M. H. et al. | 2011
- 175
-
Prognostic factors in women treated for ovarian yolk sac tumour: A retrospective analysis of 84 casesde La Motte Rouge, T. / Pautier, P. / Rey, A. / Duvillard, P. / Kerbrat, P. / Troalen, F. / Morice, P. / Haie-Meder, C. / Culine, S. / Lhomme, C. et al. | 2011
- 183
-
Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)Greimel, E. / Nordin, A. / Lanceley, A. / Creutzberg, C. L. / van de Poll-Franse, L. V. / Radisic, V. B. / Galalae, R. / Schmalz, C. / Barlow, E. / Jensen, P. T. et al. | 2011
- 191
-
Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: An analysis of 163 patientsTsolakidis, D. / Amant, F. / Leunen, K. / Cadron, I. / Neven, P. / Vergote, I. et al. | 2011
- 199
-
A phase I, dose-escalation study of pomalidomide (CC-4047) in combination with gemcitabine in metastatic pancreas cancerInfante, J. R. / Jones, S. F. / Bendell, J. C. / Spigel, D. R. / Yardley, D. A. / Weekes, C. D. / Messersmith, W. A. / Hainsworth, J. D. / Burris, H. A. et al. | 2011
- 206
-
Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancerFischer von Weikersthal, L. / Schalhorn, A. / Stauch, M. / Quietzsch, D. / Maubach, P. A. / Lambertz, H. / Oruzio, D. / Schlag, R. / Weigang-Kohler, K. / Vehling-Kaiser, U. et al. | 2011
- 215
-
Are patients in clinical trials representative of the general population? Dose intensity and toxicities associated with FE100C-D chemotherapy in a non-trial population of node positive breast cancer patients compared with PACS-01 trial groupFraser, J. / Steele, N. / Al Zaman, A. / Yule, A. et al. | 2011
- 221
-
Follow-up care amongst long-term childhood cancer survivors: A report from the Swiss Childhood Cancer Survivor StudyRebholz, C. E. / von der Weid, N. X. / Michel, G. / Niggli, F. K. / Kuehni, C. E. et al. | 2011
- 230
-
Phase II study of gemcitabine combined with oxaliplatin in relapsed or refractory paediatric solid malignancies: An innovative therapy for children with Cancer European Consortium StudyGeoerger, B. / Chisholm, J. / Le Deley, M. C. / Gentet, J. C. / Zwaan, C. M. / Dias, N. / Jaspan, T. / Mc Hugh, K. / Couanet, D. / Hain, S. et al. | 2011
- 239
-
Prognostic significance of the initial cerebro-spinal fluid (CSF) involvement of children with acute lymphoblastic leukaemia (ALL) treated without cranial irradiation: Results of European Organization for Research and Treatment of Cancer (EORTC) Children Leukemia Group study 58881Sirvent, N. / Suciu, S. / Rialland, X. / Millot, F. / Benoit, Y. / Plantaz, D. / Ferster, A. / Robert, A. / Lutz, P. / Nelken, B. et al. | 2011
- 248
-
The relationship between new-onset diabetes mellitus and pancreatic cancer risk: A case-control studyBen, Q. / Cai, Q. / Li, Z. / Yuan, Y. / Ning, X. / Deng, S. / Wang, K. et al. | 2011
- 255
-
False-positive Human Papillomavirus DNA tests in cervical screening: It is all in a definitionRebolj, M. / Pribac, I. / Lynge, E. et al. | 2011
- 262
-
Relationship between changes in haemoglobin A1C and prostate-specific antigen in healthy menOhwaki, K. / Endo, F. / Muraishi, O. / Yano, E. et al. | 2011
- 267
-
Lifestyle factors associated concurrently and prospectively with co-morbid cardiovascular disease in a population-based cohort of colorectal cancer survivorsHawkes, A. L. / Lynch, B. M. / Owen, N. / Aitken, J. F. et al. | 2011
- 277
-
Sorafenib tosylate and paclitaxel induce anti-angiogenic, anti-tumour and anti-resorptive effects in experimental breast cancer bone metastasesMerz, M. / Komljenovic, D. / Zwick, S. / Semmler, W. / Bauerle, T. et al. | 2011
- 287
-
Prognostic determinants in epithelioid sarcomaGasparini, P. / Facchinetti, F. / Boeri, M. / Lorenzetto, E. / Livio, A. / Gronchi, A. / Ferrari, A. / Massimino, M. / Spreafico, F. / Giangaspero, F. et al. | 2011
- 296
-
Altered CD94/NKG2A and perforin expression reduce the cytotoxic activity in malignant pleural effusionsPace, E. / Di Sano, C. / Ferraro, M. / Tipa, A. / Olivieri, D. / Spatafora, M. / Santagata, R. / Bellia, V. / Gjomarkaj, M. et al. | 2011
- 305
-
Organ specific regulation of tumour invasiveness and gelatinolytic activity at the invasive frontHadler-Olsen, E. / Wetting, H. L. / Ravuri, C. / Omair, A. / Rikardsen, O. / Svineng, G. / Kanapathippillai, P. / Winberg, J. O. / Uhlin-Hansen, L. et al. | 2011
- 316
-
Grifolin, a potent antitumour natural product upregulates death-associated protein kinase 1 DAPK1 via p53 in nasopharyngeal carcinoma cellsLuo, X. j. / Li, L. l. / Deng, Q. p. / Yu, X. f. / Yang, L. f. / Luo, F. j. / Xiao, L. b. / Chen, X. y. / Ye, M. / Liu, J. k. et al. | 2011
- 326
-
Induction of senescence markers after neo-adjuvant chemotherapy of malignant pleural mesothelioma and association with clinical outcome: An exploratory analysisSidi, R. / Pasello, G. / Opitz, I. / Soltermann, A. / Tutic, M. / Rehrauer, H. / Weder, W. / Stahel, R. A. / Felley-Bosco, E. et al. | 2011
- 333
-
Glypican-3: A new target for cancer immunotherapyHo, M. / Kim, H. et al. | 2011
- 339
-
Serum CCL2 and serum TNF-a - Two new biomarkers predict bone invasion, post-treatment distant metastasis and poor overall survival in nasopharyngeal carcinomaLu, X. / Qian, C. N. / Mu, Y. G. / Li, N. W. / Li, S. / Zhang, H. B. / Li, S. W. / Wang, F. L. / Guo, X. / Xiang, Y. Q. et al. | 2011
- 347
-
Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide studyOlsson, L. I. / Granstrom, F. / Glimelius, B. et al. | 2011
- 354
-
Is concurrent radiation therapy required in patients receiving preoperative chemotherapy for adenocarcinoma of the oesophagus? A randomised phase II trialBurmeister, B. H. / Thomas, J. M. / Burmeister, E. A. / Walpole, E. T. / Harvey, J. A. / Thomson, D. B. / Barbour, A. P. / Gotley, D. C. / Smithers, B. M. et al. | 2011
- 361
-
Prognostic value of serial blood S100B determinations in stage IIB-III melanoma patients: A corollary study to EORTC trial 18952Bouwhuis, M. G. / Suciu, S. / Kruit, W. / Sales, F. / Stoitchkov, K. / Patel, P. / Cocquyt, V. / Thomas, J. / Lienard, D. / Eggermont, A. M. et al. | 2011
- 369
-
The effect of prophylactic calcium and magnesium infusions on the incidence of neurotoxicity and clinical outcome of oxaliplatin-based systemic treatment in advanced colorectal cancer patientsKnijn, N. / Tol, J. / Koopman, M. / Werter, M. J. / Imholz, A. L. / Valster, F. A. / Mol, L. / Vincent, A. D. / Teerenstra, S. / Punt, C. J. et al. | 2011
- 375
-
Reproducibility and validation of tumour stroma ratio scoring on oesophageal adenocarcinoma biopsiesCourrech Staal, E. F. / Smit, V. T. / van Velthuysen, M. L. / Spitzer-Naaykens, J. M. / Wouters, M. W. / Mesker, W. E. / Tollenaar, R. A. / van Sandick, J. W. et al. | 2011
- 383
-
Reliability and construct validity of the oral mucositis daily questionnaire in children with cancerTomlinson, D. / Ethier, M. C. / Judd, P. / Doyle, J. / Gassas, A. / Naqvi, A. / Sung, L. et al. | 2011
- 389
-
Pilot study of F18-Fluorodeoxyglucose Positron Emission Tomography/computerised tomography in Wilms' tumour: Correlation with conventional imaging, pathology and immunohistochemistryBegent, J. / Sebire, N. J. / Levitt, G. / Brock, P. / Jones, K. P. / Ell, P. / Gordon, I. / Anderson, J. et al. | 2011
- 397
-
Sexual function and experience among long-term survivors of childhood cancerSundberg, K. K. / Lampic, C. / Arvidson, J. / Helstrom, L. / Wettergren, L. et al. | 2011
- 404
-
C-reactive protein-associated genetic variants and cancer risk: Findings from FINRISK 1992, FINRISK 1997 and Health 2000 studiesHeikkila, K. / Silander, K. / Salomaa, V. / Jousilahti, P. / Koskinen, S. / Pukkala, E. / Perola, M. et al. | 2011
- 413
-
Polymorphic variation in the androgen receptor gene: Association with risk of testicular germ cell cancer and metastatic diseaseVastermark, a. / Giwercman, Y. L. / Hagstromer, O. / De-Meyts, E. R. / Eberhard, J. / Stahl, O. / Cedermark, G. C. / Rastkhani, H. / Daugaard, G. / Arver, S. et al. | 2011
- 420
-
Genetic variability of the fatty acid synthase pathway is not associated with prostate cancer risk in the European Prospective Investigation on Cancer (EPIC)Campa, D. / Husing, A. / Chang-Claude, J. / Dostal, L. / Boeing, H. / Kroger, J. / Tjonneland, A. / Roswall, N. / Overvad, K. / Dahm, C. C. et al. | 2011
- 428
-
Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness?de Kok, I. M. / Habbema, J. D. / van Rosmalen, J. / van Ballegooijen, M. et al. | 2011
- 436
-
Consumption of animal products, olive oil and dietary fat and results from the Belgian case-control study on bladder cancer riskBrinkman, M. T. / Buntinx, F. / Kellen, E. / Van Dongen, M. C. / Dagnelie, P. C. / Muls, E. / Zeegers, M. P. et al. | 2011
- 443
-
Oncogenic mutations in gastric cancer with microsatellite instabilityCorso, G. / Velho, S. / Paredes, J. / Pedrazzani, C. / Martins, D. / Milanezi, F. / Pascale, V. / Vindigni, C. / Pinheiro, H. / Leite, M. et al. | 2011
- 452
-
Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastasesUchida, D. / Onoue, T. / Kuribayashi, N. / Tomizuka, Y. / Tamatani, T. / Nagai, H. / Miyamoto, Y. et al. | 2011
- 460
-
Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rateSvobodova, S. / Browning, J. / MacGregor, D. / Pollara, G. / Scolyer, R. A. / Murali, R. / Thompson, J. F. / Deb, S. / Azad, A. / Davis, I. D. et al. | 2011
- 470
-
Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in miceFedele, M. / Visone, R. / De Martino, I. / Palmieri, D. / Valentino, T. / Esposito, F. / Klein-Szanto, A. / Arra, C. / Ciarmiello, A. / Croce, C. M. et al. | 2011
- 479
-
A model of vascular tumour growth in mice combining longitudinal tumour size data with histological biomarkersRibba, B. / Watkin, E. / Tod, M. / Girard, P. / Grenier, E. / You, B. / Giraudo, E. / Freyer, G. et al. | 2011
- 491
-
Investment of palliative medicine in bridging the gap with academia: A call to actionMoroni, M. / Bolognesi, D. / Muciarelli, P. A. / Abernethy, A. P. / Biasco, G. et al. | 2011
- 496
-
Frontiers in targeting glioma stem cellsFrosina, G. et al. | 2011
- 508
-
Herbal therapy use by cancer patients: A literature review on case reportsOlaku, O. / White, J. D. et al. | 2011
- 515
-
Feasibility of metronomic oral cyclophosphamide plus prednisolone in elderly patients with inoperable or metastatic soft tissue sarcomaMir, O. / Domont, J. / Cioffi, A. / Bonvalot, S. / Boulet, B. / Le Pechoux, C. / Terrier, P. / Spielmann, M. / Le Cesne, A. et al. | 2011
- 520
-
MAPK and PI3K signalling differentially regulate angiogenic and lymphangiogenic cytokine secretion in squamous cell carcinoma of the head and neckLuangdilok, S. / Box, C. / Harrington, K. / Rhys-Evans, P. / Eccles, S. et al. | 2011
- 530
-
Six-month postoperative quality of life predicts long-term survival after oesophageal cancer surgeryDjarv, T. / Lagergren, P. et al. | 2011
- 536
-
An analysis of research activity in major UK cancer centresSullivan, R. / Lewison, G. / Purushotham, A. D. et al. | 2011
- 545
-
The excess burden of side-effects from treatment in men allocated to screening for prostate cancer. The Goteborg randomised population-based prostate cancer screening trialCarlsson, S. / Aus, G. / Bergdahl, S. / Khatami, A. / Lodding, P. / Stranne, J. / Hugosson, J. et al. | 2011
- 554
-
Validation of the QUAL-EC for assessing quality of life in patients with advanced cancerLo, C. / Burman, D. / Swami, N. / Gagliese, L. / Rodin, G. / Zimmermann, C. et al. | 2011
- 561
-
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group ProjectMoroz, V. / Machin, D. / Faldum, A. / Hero, B. / Iehara, T. / Mosseri, V. / Ladenstein, R. / Bernardi, B. D. / Rubie, H. / Berthold, F. et al. | 2011
- 572
-
Short topotecan-based induction regimen in newly diagnosed high-risk neuroblastomaDe Ioris, M. A. / Castellano, A. / Ilari, I. / Garganese, M. C. / Natali, G. / Inserra, A. / Vito, R. D. / Rava, L. / Pasquale, M. D. / Locatelli, F. et al. | 2011
- 579
-
Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population-based study of 808 cases in 1993-2007Reichgelt, B. A. / Visser, O. et al. | 2011
- 586
-
Does the time interval between first and last birth influence the risk of endometrial and ovarian cancer?Bevier, M. / Sundquist, J. / Hemminki, K. et al. | 2011
- 592
-
Parity, early menopause and the incidence of bladder cancer in women: A case-control study and meta-analysisDietrich, K. / Demidenko, E. / Schned, A. / Zens, M. S. / Heaney, J. / Karagas, M. R. et al. | 2011
- 600
-
S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9Sapkota, D. / Bruland, O. / Costea, D. E. / Haugen, H. / Vasstrand, E. N. / Ibrahim, S. O. et al. | 2011
- 611
-
Mucosal immune environment in colonic carcinogenesis: CD80 up-regulation in colonic dysplasia in ulcerative colitisScarpa, M. / Bortolami, M. / Cecchetto, A. / Faggian, D. / Kotsafti, A. / Ruffolo, C. / Navaglia, F. / Pozza, A. / D'Inca, R. / Plebani, M. et al. | 2011
- 620
-
Impact of smoking on the expression of claudins in lung carcinomaMerikallio, H. / Kaarteenaho, R. / Paakko, P. / Lehtonen, S. / Hirvikoski, P. / Makitaro, R. / Harju, T. / Soini, Y. et al. | 2011
- 631
-
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancerCorso, G. / Pedrazzani, C. / Pinheiro, H. / Fernandes, E. / Marrelli, D. / Rinnovati, A. / Pascale, V. / Seruca, R. / Oliveira, C. / Roviello, F. et al. | 2011
- 640
-
The acridone derivative MBLI-87 sensitizes breast cancer resistance protein-expressing xenografts to irinotecanArnaud, O. / Boumendjel, A. / Geze, A. / Honorat, M. / Matera, E. L. / Guitton, J. / Stein, W. D. / Bates, S. E. / Falson, P. / Dumontet, C. et al. | 2011
- 649
-
Management of cerebral metastasis: Evidence-based approach for surgery, stereotactic radiosurgery and radiotherapyJenkinson, M. D. / Haylock, B. / Shenoy, A. / Husband, D. / Javadpour, M. et al. | 2011
- 656
-
Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: Combined analyses of NPC-9901 and NPC-9902 TrialsLee, A. W. / Tung, S. Y. / Ngan, R. K. / Chappell, R. / Chua, D. T. / Lu, T. X. / Siu, L. / Tan, T. / Chan, L. K. / Ng, W. T. et al. | 2011
- 667
-
Normative data for the EORTC QLQ-C30 and EORTC-sexuality items in the general Dutch populationvan de Poll-Franse, L. V. / Mols, F. / Gundy, C. M. / Creutzberg, C. L. / Nout, R. A. / Verdonck-de Leeuw, I. M. / Taphoorn, M. J. / Aaronson, N. K. et al. | 2011
- 676
-
The value of routine physical examination in the follow up of women with a history of early breast cancerLu, W. / de Bock, G. H. / Schaapveld, M. / Baas, P. C. / Wiggers, T. / Jansen, L. et al. | 2011
- 683
-
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: Final results from CALGB trial 79809Shapiro, C. L. / Halabi, S. / Hars, V. / Archer, L. / Weckstein, D. / Kirshner, J. / Sikov, W. / Winer, E. / Burstein, H. J. / Hudis, C. et al. | 2011
- 690
-
Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinomaBusse, A. / Asemissen, A. M. / Nonnenmacher, A. / Braun, F. / Ochsenreither, S. / Stather, D. / Fusi, A. / Schmittel, A. / Miller, K. / Thiel, E. et al. | 2011
- 697
-
Recommendations for capture, validation and summarisation of data from studies using RECISTPaules, M. / Casey, M. / Williams, G. / Swann, R. S. / Murphy, P. S. / Salazar, V. M. / Foose, D. / Bailey, B. / Therasse, P. et al. | 2011
- 702
-
The development of evidence-based European guidelines on the management of depression in palliative cancer careRayner, L. / Price, A. / Hotopf, M. / Higginson, I. J. et al. | 2011
- 713
-
Does pain intensity predict a poor opioid response in cancer patients?Mercadante, S. / Gebbia, V. / David, F. / Aielli, F. / Verna, L. / Porzio, G. / Ferrera, P. / Casuccio, A. / Ficorella, C. et al. | 2011
- 718
-
Microscopic neoplastic thrombosis in localised nephroblastoma: Does it influence outcome?De Ioris, M. A. / Aloi, I. / Camassei, F. D. / Rava, L. / Boldrini, R. / De Sio, L. / De Laurentis, C. / Castellano, A. / Crocoli, A. / Locatelli, F. et al. | 2011
- 724
-
Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: Results of a pooled analysis from United States and European groupsFerrari, A. / Miceli, R. / Rey, A. / Oberlin, O. / Orbach, D. / Brennan, B. / Mariani, L. / Carli, M. / Bisogno, G. / Cecchetto, G. et al. | 2011
- 732
-
Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climateNewton-Bishop, J. A. / Chang, Y. M. / Elliott, F. / Chan, M. / Leake, S. / Karpavicius, B. / Haynes, S. / Fitzgibbon, E. / Kukalizch, K. / Randerson-Moor, J. et al. | 2011
- 742
-
Chlamydia pneumoniae infection and lung cancer risk: A meta-analysisZhan, P. / Suo, L. j. / Qian, Q. / Shen, X. k. / Qiu, L. X. / Yu, L. k. / Song, Y. et al. | 2011
- 748
-
Physical activity and lymphoid neoplasms in the European Prospective Investigation into Cancer and nutrition (EPIC)van Veldhoven, C. M. / Khan, A. E. / Teucher, B. / Rohrmann, S. / Raaschou-Nielsen, O. / Tjonneland, A. / Overvad, K. / Vigl, M. / Boeing, H. / Benetou, V. et al. | 2011
- 761
-
Caveolin 1 is a marker of poor differentiation in RhabdomyosarcomaRossi, S. / Poliani, P. L. / Cominelli, M. / Bozzato, A. / Vescovi, R. / Monti, E. / Fanzani, A. et al. | 2011
- 773
-
A novel hybrid peptide targeting EGFR-expressing cancersKohno, M. / Horibe, T. / Haramoto, M. / Yano, Y. / Ohara, K. / Nakajima, O. / Matsuzaki, K. / Kawakami, K. et al. | 2011
- 784
-
A five-microRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosisLiu, R. / Zhang, C. / Hu, Z. / Li, G. / Wang, C. / Yang, C. / Huang, D. / Chen, X. / Zhang, H. / Zhuang, R. et al. | 2011
- 792
-
Protein kinase CK2a subunit over-expression correlates with metastatic risk in breast carcinomas: Quantitative immunohistochemistry in tissue microarraysGiusiano, S. / Cochet, C. / Filhol, O. / Duchemin-Pelletier, E. / Secq, V. / Bonnier, P. / Carcopino, X. / Boubli, L. / Birnbaum, D. / Garcia, S. et al. | 2011
- 802
-
Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomasDucray, F. / Mokhtari, K. / Criniere, E. / Idbaih, A. / Marie, Y. / Dehais, C. / Paris, S. / Carpentier, C. / Dieme, M. J. / Adam, C. et al. | 2011
- 811
-
Time for paediatric febrile neutropenia guidelines - children are not little adultsSung, L. / Phillips, R. / Lehrnbecher, T. et al. | 2011
- 814
-
Previous thalidomide therapy may not affect lenalidomide response and outcome in relapse or refractory multiple myeloma patientsGuglielmelli, T. / Bringhen, S. / Rrodhe, S. / Gay, F. / Cavallo, F. / Berruti, A. / Montefusco, V. / Piro, E. / Benevolo, G. / Petrucci, M. T. et al. | 2011
- 819
-
Statins and prostate cancer: Molecular and clinical aspectsPapadopoulos, G. / Delakas, D. / Nakopoulou, L. / Kassimatis, T. et al. | 2011
- 831
-
Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: A prospective cross-over drug-drug interaction studyvan der Bol, J. M. / Loos, W. J. / de Jong, F. A. / van Meerten, E. / Konings, I. R. / Lam, M. H. / de Bruijn, P. / Wiemer, E. A. / Verweij, J. / Mathijssen, R. H. et al. | 2011
- 839
-
Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapyRodriguez, J. / Boni, V. / Hernandez, A. / Bitarte, N. / Zarate, R. / Ponz-Sarvise, M. / Chopitea, A. / Bandres, E. / Garcia-Foncillas, J. et al. | 2011
- 848
-
Changes of bone resorption marker (NTX) in chemotherapy plus zoledronic acid versus chemotherapy alone for nasopharyngeal cancer patients with bone metastasesZhao, Y. Y. / Xue, C. / Hou, X. / Liao, H. / Li, S. / Zhao, H. Y. / Huang, Y. / Chen, L. K. / Xu, F. / Liu, J. L. et al. | 2011
- 854
-
Randomised controlled trials in oncology closed early for benefit: Trends in methodology, results, and interpretationBooth, C. M. / Ohorodnyk, P. / Zhu, L. / Tu, D. / Meyer, R. M. et al. | 2011
- 864
-
A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trialKitchener, H. C. / Gilham, C. / Sargent, A. / Bailey, A. / Albrow, R. / Roberts, C. / Desai, M. / Mather, J. / Turner, A. / Moss, S. et al. | 2011
- 872
-
Stage migration after introduction of sentinel lymph node dissection in breast cancer treatment in Denmark: A nationwide studyTvedskov, T. F. / Jensen, M. B. / Balslev, E. / Ejlertsen, B. / Kroman, N. et al. | 2011
- 879
-
Preoperative MRI and surgical management in patients with nonpalpable breast cancer: The MONET - Randomised controlled trialPeters, N. H. / van Esser, S. / van den Bosch, M. A. / Storm, R. K. / Plaisier, P. W. / van Dalen, T. / Diepstraten, S. C. / Weits, T. / Westenend, P. J. / Stapper, G. et al. | 2011
- 887
-
Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitionsCserni, G. / Amendoeira, I. / Bianchi, S. / Chmielik, E. / DeGaetano, J. / Faverly, D. / Figueiredo, P. / Foschini, M. P. / Grabau, D. / Jacquemier, J. et al. | 2011
- 895
-
Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trialsGelderblom, H. / Jinks, R. C. / Sydes, M. / Bramwell, V. H. / van Glabbeke, M. / Grimer, R. J. / Hogendoorn, P. C. / McTiernan, A. / Lewis, I. J. / Nooij, M. A. et al. | 2011
- 903
-
Prediction of prostate cancer in unscreened men: External validation of a risk calculatorvan Vugt, H. A. / Roobol, M. J. / Kranse, R. / Maattanen, L. / Finne, P. / Hugosson, J. / Bangma, C. H. / Schroder, F. H. / Steyerberg, E. W. et al. | 2011
- 910
-
Socioeconomic inequalities in prognostic markers of non-Hodgkin lymphoma: Analysis of a national clinical databaseFrederiksen, B. L. / Brown, P. d. / Dalton, S. O. / Steding-Jessen, M. / Osler, M. et al. | 2011
- 918
-
High claudin-7 expression is associated with a poor response to platinum-based chemotherapy in epithelial ovarian carcinomaKim, C. J. / Lee, J. W. / Choi, J. J. / Choi, H. Y. / Park, Y. A. / Jeon, H. K. / Sung, C. O. / Song, S. Y. / Lee, Y. Y. / Choi, C. H. et al. | 2011
- 926
-
TAZ/WWTR1 is overexpressed in papillary thyroid carcinomade Cristofaro, T. / Di Palma, T. / Ferraro, A. / Corrado, A. / Lucci, V. / Franco, R. / Fusco, A. / Zannini, M. et al. | 2011
- 934
-
Inhibitor of DNA binding-1 induces mesenchymal features and promotes invasiveness in thyroid tumour cellsCiarrocchi, A. / Piana, S. / Valcavi, R. / Gardini, G. / Casali, B. et al. | 2011
- 946
-
Risk for second primary non-breast cancer in pre- and postmenopausal women with breast cancer not treated with chemotherapy, radiotherapy or endocrine therapyLangballe, R. / Olsen, J. H. / Andersson, M. / Mellemkjaer, L. et al. | 2011
- 953
-
miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasionFowler, A. / Thomson, D. / Giles, K. / Maleki, S. / Mreich, E. / Wheeler, H. / Leedman, P. / Biggs, M. / Cook, R. / Little, N. et al. | 2011
- 965
-
Paediatric intestinal cancer and polyposis due to bi-allelic PMS2 mutations: Case series, review and follow-up guidelinesHerkert, J. C. / Niessen, R. C. / Olderode-Berends, M. J. / Veenstra-Knol, H. E. / Vos, Y. J. / van der Klift, H. M. / Scheenstra, R. / Tops, C. M. / Karrenbeld, A. / Peters, F. T. et al. | 2011
- 983
-
Reducing sample sizes in two-stage phase II cancer trials by using continuous tumour shrinkage end-pointsWason, J. M. / Mander, A. P. / Eisen, T. G. et al. | 2011
- 990
-
Two or three year disease-free survival (DFS) as a primary end-point in stage III adjuvant colon cancer trials with fluoropyrimidines with or without oxaliplatin or irinotecan: Data from 12,676 patients from MOSAIC, X-ACT, PETACC-3, C-06, C-07 and C89803Sargent, D. / Shi, Q. / Yothers, G. / Van Cutsem, E. / Cassidy, J. / Saltz, L. / Wolmark, N. / Bot, B. / Grothey, A. / Buyse, M. et al. | 2011
- 997
-
Phase I trial of vandetanib and bevacizumab evaluating the VEGF and EGF signal transduction pathways in adults with solid tumours and lymphomasKummar, S. / Gutierrez, M. E. / Chen, A. / Turkbey, I. B. / Allen, D. / Horneffer, Y. R. / Juwara, L. / Cao, L. / Yu, Y. / Kim, Y. S. et al. | 2011
- 1006
-
Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: A retrospective multicentric studySchoffski, P. / Taron, M. / Jimeno, J. / Grosso, F. / Sanfilipio, R. / Casali, P. G. / Cesne, A. L. / Jones, R. L. / Blay, J. Y. / Poveda, A. et al. | 2011
- 1013
-
Prognostic value of survivin expression in parotid gland cancer in consideration of different histological subtypesStenner, M. / Demgensky, A. / Molls, C. / Hardt, A. / Luers, J. C. / Grosheva, M. / Huebbers, C. U. / Klussmann, J. P. et al. | 2011
- 1021
-
Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: Interval breast cancers at 1year follow-upCorsetti, V. / Houssami, N. / Ghirardi, M. / Ferrari, A. / Speziani, M. / Bellarosa, S. / Remida, G. / Gasparotti, C. / Galligioni, E. / Ciatto, S. et al. | 2011
- 1027
-
Nurse-led telephone follow-up and an educational group programme after breast cancer treatment: Results of a 2x2 randomised controlled trialKimman, M. L. / Dirksen, C. D. / Voogd, A. C. / Falger, P. / Gijsen, B. C. / Thuring, M. / Lenssen, A. / van der Ent, F. / Verkeyn, J. / Haekens, C. et al. | 2011
- 1037
-
A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II studyVillanueva, C. / Awada, A. / Campone, M. / Machiels, J. P. / Besse, T. / Magherini, E. / Dubin, F. / Semiond, D. / Pivot, X. et al. | 2011
- 1046
-
First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genesMorak, M. / Massdorf, T. / Sykora, H. / Kerscher, M. / Holinski-Feder, E. et al. | 2011
- 1056
-
Sociodemographic factors and incidence of melanoma in the Netherlands, 1994-2005van der Aa, M. A. / de Vries, E. / Hoekstra, H. J. / Coebergh, J. W. / Siesling, S. et al. | 2011
- 1061
-
Increased cancer risks among arthroplasty patients: 30year follow-up of the Swedish Knee Arthroplasty RegisterWagner, P. / Olsson, H. / Lidgren, L. / Robertsson, O. / Ranstam, J. et al. | 2011
- 1072
-
Lack of association of IL-10 gene polymorphisms with prostate cancer: Evidence from 11,581 subjectsZou, Y. F. / Wang, F. / Feng, X. L. / Tian, Y. H. / Tao, J. H. / Pan, F. M. / Huang, F. et al. | 2011
- 1080
-
Brachyury expression predicts poor prognosis at early stages of colorectal cancerKilic, N. / Feldhaus, S. / Kilic, E. / Tennstedt, P. / Wicklein, D. / Wasielewski, R. v. / Viebahn, C. / Kreipe, H. / Schumacher, U. et al. | 2011
- 1086
-
Expression of DNA repair genes in ovarian cancer samples: Biological and clinical considerationsGanzinelli, M. / Mariani, P. / Cattaneo, D. / Fossati, R. / Fruscio, R. / Corso, S. / Ricci, F. / Broggini, M. / Damia, G. et al. | 2011
- 1095
-
Differentiation of human rhabdomyosarcoma RD cells is regulated by reciprocal, functional interactions between myostatin, p38 and extracellular regulated kinase signalling pathwaysRossi, S. / Stoppani, E. / Puri, P. L. / Fanzani, A. et al. | 2011
- 1106
-
Prognostic value of opioid binding protein/cell adhesion molecule-like promoter methylation in bladder carcinomaDuarte-Pereira, S. / Paiva, F. / Costa, V. L. / Ramalho-Carvalho, J. / Savva-Bordalo, J. / Rodrigues, A. / Ribeiro, F. R. / Silva, V. M. / Oliveira, J. / Henrique, R. et al. | 2011
- 1115
-
Des-g-carboxyl prothrombin induces matrix metalloproteinase activity in hepatocellular carcinoma cells by involving the ERK1/2 MAPK signalling pathwayYue, P. / Gao, Z. H. / Xue, X. / Cui, S. X. / Zhao, C. R. / Yuan, Y. / Yin, Z. / Inagaki, Y. / Kokudo, N. / Tang, W. et al. | 2011
- 1125
-
Assessing downgrading of locally advanced rectal cancer after chemo-radiotherapyZlobec, I. et al. | 2011
- 1127
-
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosisBabashah, S. / Soleimani, M. et al. | 2011
- 1138
-
Prognostic importance of Mandard tumour regression grade following pre-operative chemo/radiotherapy for locally advanced rectal cancerDhadda, A. S. / Dickinson, P. / Zaitoun, A. M. / Gandhi, N. / Bessell, E. M. et al. | 2011
- 1146
-
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancerHawkes, E. / Okines, A. F. / Papamichael, D. / Rao, S. / Ashley, S. / Charalambous, H. / Koukouma, A. / Chau, I. / Cunningham, D. et al. | 2011
- 1152
-
A new, simple and objective prognostic score for phase I cancer patientsFussenich, L. M. / Desar, I. M. / Peters, M. E. / Teerenstra, S. / van der Graaf, W. T. / Timmer-Bonte, J. N. / van Herpen, C. M. et al. | 2011
- 1161
-
Haematologic toxicities associated with the addition of bevacizumab in cancer patientsSchutz, F. A. / Jardim, D. L. / Je, Y. / Choueiri, T. K. et al. | 2011
- 1175
-
Economic evaluation of four follow-up strategies after curative treatment for breast cancer: Results of an RCTKimman, M. L. / Dirksen, C. D. / Voogd, A. C. / Falger, P. / Gijsen, B. C. / Thuring, M. / Lenssen, A. / van der Ent, F. / Verkeyn, J. / Haekens, C. et al. | 2011
- 1186
-
Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre studySaxena, N. / Hartman, M. / Aziz, R. / Rapiti, E. / Bhoo Pathy, N. / Lim, S. E. / Iau, P. / Taib, N. A. / Schaffar, R. / Neyroud-Caspar, I. et al. | 2011
- 1193
-
The prognostic value of fast molecular response of marrow disease in patients aged over 1year with stage 4 neuroblastomaStutterheim, J. / Zappeij-Kannegieter, L. / Versteeg, R. / Caron, H. N. / van der Schoot, C. E. / Tytgat, G. A. et al. | 2011
- 1203
-
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerCastro, F. A. / Forsti, A. / Buch, S. / Kalthoff, H. / Krauss, C. / Bauer, M. / Egberts, J. / Schniewind, B. / Broering, D. C. / Schreiber, S. et al. | 2011
- 1211
-
The prevalence of premalignant gastric lesions in asymptomatic patients: Predicting the future incidence of gastric cancerden Hoed, C. M. / van Eijck, B. C. / Capelle, L. G. / van Dekken, H. / Biermann, K. / Siersema, P. D. / Kuipers, E. J. et al. | 2011
- 1219
-
The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanomaTentori, L. / Dorio, A. S. / Mazzon, E. / Muzi, A. / Sau, A. / Cuzzocrea, S. / Vernole, P. / Federici, G. / Caccuri, A. M. / Graziani, G. et al. | 2011
- 1231
-
Primary resistance to cetuximab in a panel of patient-derived tumour xenograft models: Activation of MET as one mechanism for drug resistanceKrumbach, R. / Schuler, J. / Hofmann, M. / Giesemann, T. / Fiebig, H. H. / Beckers, T. et al. | 2011
- 1244
-
Lack of compensatory pAKT activation and eIF4E phosphorylation of lymphoma cells towards mTOR inhibitor, RAD001Kuo, S. H. / Hsu, C. H. / Chen, L. T. / Lu, Y. S. / Lin, C. H. / Yeh, P. Y. / Jeng, H. J. / Gao, M. / Yeh, K. H. / Cheng, A. L. et al. | 2011
- 1258
-
Expression of insulin-like growth factor system components in Ewing's sarcoma and their association with survivalScotlandi, K. / Manara, M. C. / Serra, M. / Marino, M. T. / Ventura, S. / Garofalo, C. / Alberghini, M. / Magagnoli, G. / Ferrari, S. / Lopez-Guerrero, J. A. et al. | 2011
- 1267
-
Gene expression profiling of human angiotropic primary melanoma: Selection of 15 differentially expressed genes potentially involved in extravascular migratory metastasisLugassy, C. / Lazar, V. / Dessen, P. / van den Oord, J. J. / Winnepenninckx, V. / Spatz, A. / Bagot, M. / Bensussan, A. / Janin, A. / Eggermont, A. M. et al. | 2011
- 1276
-
Microvascular biodistribution of L19-SIP in angiogenesis targeting strategiesCzabanka, M. / Parmaksiz, G. / Bayerl, S. H. / Nieminen, M. / Trachsel, E. / Menssen, H. D. / Erber, R. / Neri, D. / Vajkoczy, P. et al. | 2011
- 1285
-
The pharmacoeconomics of spiralling cancer drug costs - Is there a viable solution?Alifrangis, C. / Krell, J. / Stebbing, J. et al. | 2011
- 1287
-
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinomaPorta, C. / Osanto, S. / Ravaud, A. / Climent, M. A. / Vaishampayan, U. / White, D. A. / Creel, P. / Dickow, B. / Fischer, P. / Gornell, S. S. et al. | 2011
- 1299
-
The development of a value based pricing index for new drugs in metastatic colorectal cancerDranitsaris, G. / Truter, I. / Lubbe, M. S. et al. | 2011
- 1305
-
Mutational spectrum and therapy response of metastasized GIST in Central Switzerland - A population-based studyRossle, M. / Hirschmann, A. / Diebold, J. et al. | 2011
- 1312
-
Prognostic significance of interim 18F-FDG PET/CT after three or four cycles of R-CHOP chemotherapy in the treatment of diffuse large B-cell lymphomaYang, D. H. / Min, J. J. / Song, H. C. / Jeong, Y. Y. / Chung, W. K. / Bae, S. Y. / Ahn, J. S. / Kim, Y. K. / Bom, H. S. / Chung, I. J. et al. | 2011
- 1319
-
Topoisomerase II-alpha protein expression and histological response following doxorubicin-based induction chemotherapy predict survival of locally advanced soft tissues sarcomasRodrigo, R. S. / Nathalie, A. / Elodie, T. / Gonzalo, G. A. / Philippe, T. / Francoise, D. / Julien, D. / Angela, C. / Berenice, B. / Jean-Yves, B. et al. | 2011
- 1328
-
Phase I safety and pharmacokinetic study of SU-014813 in combination with docetaxel in patients with advanced solid tumoursde Jonge, M. J. / Dumez, H. / Kitzen, J. J. / Beuselinck, B. / Verweij, J. / Courtney, R. / Battista, A. / Brega, N. / Schoffski, P. et al. | 2011
- 1336
-
Phase II trial of the combination of carboplatin and irinotecan in elderly patients with small-cell lung cancerMurata, Y. / Hirose, T. / Yamaoka, T. / Shirai, T. / Okuda, K. / Sugiyama, T. / Kusumoto, S. / Nakashima, M. / Ohmori, T. / Adachi, M. et al. | 2011
- 1343
-
A systematic review and meta-analysis of KRAS status as the determinant of response to anti-EGFR antibodies and the impact of partner chemotherapy in metastatic colorectal cancerAdelstein, B. A. / Dobbins, T. A. / Harris, C. A. / Marschner, I. C. / Ward, R. L. et al. | 2011
- 1355
-
Weekly docetaxel in metastatic breast cancer patients: No superior benefits compared to three-weekly docetaxelSchroder, C. P. / de Munck, L. / Westermann, A. M. / Smit, W. M. / Creemers, G. J. / de Graaf, H. / Stouthard, J. M. / van Deijk, G. / Erjavec, Z. / van Bochove, A. et al. | 2011
- 1363
-
Psychosocial group intervention for patients with primary breast cancer: A randomised trialBoesen, E. H. / Karlsen, R. / Christensen, J. / Paaschburg, B. / Nielsen, D. / Bloch, I. S. / Christiansen, B. / Jacobsen, K. / Johansen, C. et al. | 2011
- 1373
-
The low incidence of secondary acute myelogenous leukaemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukaemia: A report from the Dana-Farber Cancer Institute ALL ConsortiumVrooman, L. M. / Neuberg, D. S. / Stevenson, K. E. / Asselin, B. L. / Athale, U. H. / Clavell, L. / Cole, P. D. / Kelly, K. M. / Larsen, E. C. / Laverdiere, C. et al. | 2011
- 1380
-
Neurocognitive functioning and health-related behaviours in adult survivors of childhood cancer: A report from the Childhood Cancer Survivor StudyKrull, K. R. / Annett, R. D. / Pan, Z. / Ness, K. K. / Nathan, P. C. / Srivastava, D. K. / Stovall, M. / Robison, L. L. / Hudson, M. M. et al. | 2011
- 1389
-
Treatment of recurrent central nervous system primitive neuroectodermal tumours in children and adolescents: Results of a Children's Cancer and Leukaemia Group studyPizer, B. / Donachie, P. H. / Robinson, K. / Taylor, R. E. / Michalski, A. / Punt, J. / Ellison, D. W. / Picton, S. et al. | 2011
- 1398
-
Differences according to educational level in the management and survival of colorectal cancer in SwedenCavalli-Bjorkman, N. / Lambe, M. / Eaker, S. / Sandin, F. / Glimelius, B. et al. | 2011
- 1407
-
Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndromeManders, P. / Spruijt, L. / Kets, C. M. / Willems, H. W. / Bodmer, D. / Hebeda, K. M. / Nagtegaal, I. D. / van Krieken, J. H. / Ligtenberg, M. J. / Hoogerbrugge, N. et al. | 2011
- 1414
-
Overexpression of Dicer predicts poor survival in colorectal cancerFaber, C. / Horst, D. / Hlubek, F. / Kirchner, T. et al. | 2011
- 1420
-
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapyFaratian, D. / Um, I. / Wilson, D. S. / Mullen, P. / Langdon, S. P. / Harrison, D. J. et al. | 2011
- 1432
-
Anticancer effects of the p53 activator nutlin-3 in Ewing's sarcoma cellsSonnemann, J. / Palani, C. D. / Wittig, S. / Becker, S. / Eichhorn, F. / Voigt, A. / Beck, J. F. et al. | 2011
- 1443
-
Phase 1 trials of molecular targeted therapies: Are we evaluating toxicities properly?Soria, J. C. et al. | 2011
- 1446
-
Motor vehicle exposure and risk of oesophageal adenocarcinomaLagergren, J. / Jansson, C. / Lu, Y. et al. | 2011
- 1450
-
The preclinical and clinical activity of aviscumine: A potential anticancer drugZwierzina, H. / Bergmann, L. / Fiebig, H. / Aamdal, S. / Schoffski, P. / Witthohn, K. / Lentzen, H. et al. | 2011
- 1458
-
Critical review of economic evaluations in multiple myeloma: An overview of the economic evidence and quality of the methodologyGaultney, J. G. / Redekop, W. K. / Sonneveld, P. / Uyl-de Groot, C. A. et al. | 2011
- 1468
-
Heterogeneity in the definition of dose-limiting toxicity in phase I cancer clinical trials of molecularly targeted agents: A review of the literatureLe Tourneau, C. / Razak, A. R. / Gan, H. K. / Pop, S. / Dieras, V. / Tresca, P. / Paoletti, X. et al. | 2011
- 1476
-
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: Final results of a randomised phase III study (EORTC 18032)Patel, P. M. / Suciu, S. / Mortier, L. / Kruit, W. H. / Robert, C. / Schadendorf, D. / Trefzer, U. / Punt, C. J. / Dummer, R. / Davidson, N. et al. | 2011
- 1484
-
A phase I study of sirolimus and bevacizumab in patients with advanced malignanciesCohen, E. E. / Sharma, M. R. / Janisch, L. / Llobrera, M. / House, L. / Wu, K. / Ramirez, J. / Fleming, G. F. / Stadler, W. M. / Ratain, M. J. et al. | 2011
- 1490
-
Reasons given by patients for participating, or not, in Phase 1 cancer trialsCatt, S. / Langridge, C. / Fallowfield, L. / Talbot, D. C. / Jenkins, V. et al. | 2011
- 1498
-
A randomised phase II trial of 1month versus 1year of adjuvant high-dose interferon a-2b in high-risk acral melanoma patientsMao, L. / Si, L. / Chi, Z. / Cui, C. / Sheng, X. / Li, S. / Tang, B. / Guo, J. et al. | 2011
- 1504
-
Adherence to national guidelines for treatment and outcome of endometrial cancer stage I in relation to co-morbidity in southern Netherlands 1995-2008Boll, D. / Verhoeven, R. H. / van der Aa, M. A. / Lybeert, M. L. / Coebergh, J. W. / Janssen-Heijnen, M. L. et al. | 2011
- 1511
-
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancerMoehler, M. / Mueller, A. / Hartmann, J. T. / Ebert, M. P. / Al-Batran, S. E. / Reimer, P. / Weihrauch, M. / Lordick, F. / Trarbach, T. / Biesterfeld, S. et al. | 2011
- 1521
-
One-month relative dose intensity of not less than 50% predicts favourable progression-free survival in sorafenib therapy for advanced renal cell carcinoma in Japanese patientsKawashima, A. / Takayama, H. / Arai, Y. / Tanigawa, G. / Nin, M. / Kajikawa, J. / Imazu, T. / Kinoshita, T. / Yasunaga, Y. / Inoue, H. et al. | 2011
- 1527
-
Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44+CD24lo cancer stem cell phenotypeReuben, J. M. / Lee, B. N. / Gao, H. / Cohen, E. N. / Mego, M. / Giordano, A. / Wang, X. / Lodhi, A. / Krishnamurthy, S. / Hortobagyi, G. N. et al. | 2011
- 1537
-
Peritumoural vascular invasion: A major determinant of triple-negative breast cancer outcomeSabatier, R. / Jacquemier, J. / Bertucci, F. / Esterni, B. / Finetti, P. / Azario, F. / Birnbaum, D. / Viens, P. / Goncalves, A. / Extra, J. M. et al. | 2011
- 1546
-
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study GroupKoch, A. / Bergman, B. / Holmberg, E. / Sederholm, C. / Ek, L. / Kosieradzki, J. / Lamberg, K. / Thaning, L. / Ydreborg, S. O. / Sorenson, S. et al. | 2011
- 1556
-
Pharmacokinetics of cyclophosphamide and its metabolites in paediatric patients receiving high-dose myeloablative therapyChinnaswamy, G. / Errington, J. / Foot, A. / Boddy, A. V. / Veal, G. J. / Cole, M. et al. | 2011
- 1564
-
Couples' communication before the wife's death to cancer and the widower's feelings of guilt or regret after the loss - A population-based investigationJonasson, J. M. / Hauksdottir, A. / Nemes, S. / Surkan, P. J. / Valdimarsdottir, U. / Onelov, E. / Steineck, G. et al. | 2011
- 1571
-
Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screeningDekker, N. / van Rossum, L. G. / Van Vugt-van Pinxteren, M. / van Stiphout, S. H. / Hermens, R. P. / van Zelst-Stams, W. A. / van Oijen, M. G. / Laheij, R. J. / Jansen, J. B. / Hoogerbrugge, N. et al. | 2011
- 1578
-
Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancerOtvos, L. / Kovalszky, I. / Riolfi, M. / Ferla, R. / Olah, J. / Sztodola, A. / Nama, K. / Molino, A. / Piubello, Q. / Wade, J. D. et al. | 2011
- 1585
-
p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteinsYu, H. / Su, J. / Xu, Y. / Kang, J. / Li, H. / Zhang, L. / Yi, H. / Xiang, X. / Liu, F. / Sun, L. et al. | 2011
- 1595
-
VEGF-SPECT with 111In-bevacizumab in stage III/IV melanoma patientsNagengast, W. B. / Hooge, M. N. / van Straten, E. M. / Kruijff, S. / Brouwers, A. H. / den Dunnen, W. F. / de Jong, J. R. / Hollema, H. / Dierckx, R. A. / Mulder, N. H. et al. | 2011
- 1603
-
Under usage of zoledronic acid in non-small cell lung cancer patients with metastatic bone disease - a short communicationCalderone, R. / Nimako, K. / Leary, A. / Popat, S. / O'Brien, M. E. et al. | 2011
- 1606
-
Body mass index and risk of multiple myeloma: A meta-analysis of prospective studiesWallin, A. / Larsson, S. C. et al. | 2011
- 1616
-
Never-ageing cellular senescenceOgrunc, M. / Fagagna, F. d. et al. | 2011
- 1623
-
Hormone replacement therapy and women with premature menopause - A cancer survivorship issueKing, J. / Wynne, C. H. / Assersohn, L. / Jones, A. et al. | 2011
- 1633
-
Cost-effectiveness of primary HPV screening for cervical cancer in Germany - a decision analysisSroczynski, G. / Schnell-Inderst, P. / Muhlberger, N. / Lang, K. / Aidelsburger, P. / Wasem, J. / Mittendorf, T. / Engel, J. / Hillemanns, P. / Petry, K. U. et al. | 2011
- 1647
-
Effect of a misspecification of response rates on type I and type II errors, in a phase II Simon designBaey, C. / Le Deley, M. C. et al. | 2011
- 1653
-
A randomised phase II study of docetaxel/oxaliplatin and docetaxel in patients with previously treated non-small cell lung cancer: An Alpe-Adria Thoracic Oncology Multidisciplinary group trial (ATOM 019)Belvedere, O. / Follador, A. / Rossetto, C. / Merlo, V. / Defferrari, C. / Sibau, A. M. / Aita, M. / Dal Bello, M. G. / Meduri, S. / Gaiardo, M. et al. | 2011
- 1660
-
The use of 24-h ambulatory blood pressure monitoring (ABPM) during the first cycle of sunitinib improves the diagnostic accuracy and management of hypertension in patients with advanced renal cancerBamias, A. / Manios, E. / Karadimou, A. / Michas, F. / Lainakis, G. / Constantinidis, C. / Deliveliotis, C. / Zakopoulos, N. / Dimopoulos, M. A. et al. | 2011
- 1669
-
Relationship between CCL5 and transforming growth factor-b1 (TGFb1) in breast cancerHartmann, M. C. / Dwyer, R. M. / Costello, M. / Potter, S. M. / Curran, C. / Hennessy, E. / Newell, J. / Griffin, D. G. / Kerin, M. J. et al. | 2011
- 1676
-
Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study groupPelzer, U. / Schwaner, I. / Stieler, J. / Adler, M. / Seraphin, J. / Dorken, B. / Riess, H. / Oettle, H. et al. | 2011
- 1682
-
Clinical and genetic factors associated with nausea and vomiting in cancer patients receiving opioidsLaugsand, E. A. / Fladvad, T. / Skorpen, F. / Maltoni, M. / Kaasa, S. / Fayers, P. / Klepstad, P. et al. | 2011
- 1692
-
Gastrointestinal stromal tumours in children and young adults: A clinicopathologic series with long-term follow-up from the database of the Cooperative Weichteilsarkom Studiengruppe (CWS)Benesch, M. / Leuschner, I. / Wardelmann, E. / Thielen, M. / Schmid, I. / Kontny, U. / Ebetsberger, G. / Frey, E. / Graf, N. / Schneider, D. T. et al. | 2011
- 1699
-
GWAS-identified colorectal cancer susceptibility locus associates with disease prognosisXing, J. / Myers, R. E. / He, X. / Qu, F. / Zhou, F. / Ma, X. / Hyslop, T. / Bao, G. / Wan, S. / Yang, H. et al. | 2011
- 1708
-
High serum angiogenin at diagnosis predicts for failure on long-term treatment response and for poor overall survival in non-Hodgkin lymphomaFang, S. / Repo, H. / Joensuu, H. / Orpana, A. / Salven, P. et al. | 2011
- 1717
-
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cellsAttias-Geva, Z. / Bentov, I. / Ludwig, D. L. / Fishman, A. / Bruchim, I. / Werner, H. et al. | 2011
- 1727
-
Adrenomedullin expression and regulation in human glioblastoma, cultured human glioblastoma cell lines and pilocytic astrocytomaMetellus, P. / Voutsinos-Porche, B. / Nanni-Metellus, I. / Colin, C. / Fina, F. / Berenguer, C. / Dussault, N. / Boudouresque, F. / Loundou, A. / Intagliata, D. et al. | 2011
- 1736
-
An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumoursKelly, R. K. / Olson, D. L. / Sun, Y. / Wen, D. / Wortham, K. A. / Antognetti, G. / Cheung, A. E. / Orozco, O. E. / Yang, L. / Bailly, V. et al. | 2011
- 1747
-
PERIOD1 (PER1) has anti-apoptotic effects, and PER3 has pro-apoptotic effects during cisplatin (CDDP) treatment in human gingival cancer CA9-22 cellsSato, F. / Wu, Y. / Bhawal, U. K. / Liu, Y. / Imaizumi, T. / Morohashi, S. / Kato, Y. / Kijima, H. et al. | 2011
- 1759
-
Is it time to abandon complete blinded independent central radiological evaluation of progression in registration trials?Pignatti, F. / Hemmings, R. / Jonsson, B. et al. | 2011
- 1763
-
Research outcomes and recommendations for the assessment of progression in cancer clinical trials from a PhRMA working groupStone, A. M. / Bushnell, W. / Denne, J. / Sargent, D. J. / Amit, O. / Chen, C. / Bailey-Iacona, R. / Helterbrand, J. / Williams, G. et al. | 2011
- 1772
-
Blinded independent central review of progression in cancer clinical trials: Results from a meta-analysisAmit, O. / Mannino, F. / Stone, A. M. / Bushnell, W. / Denne, J. / Helterbrand, J. / Burger, H. U. et al. | 2011
- 1779
-
Association between c-myc amplification and pathological complete response to neoadjuvant chemotherapy in breast cancerYasojima, H. / Shimomura, A. / Naoi, Y. / Kishi, K. / Baba, Y. / Shimazu, K. / Nakayama, T. / Kim, S. J. / Tamaki, Y. / Noguchi, S. et al. | 2011
- 1789
-
Molecular classification of hepatocellular carcinoma anno 2011van Malenstein, H. / van Pelt, J. / Verslype, C. et al. | 2011
- 1798
-
Impact of chemotherapy on health status and symptom burden of colon cancer survivors: A population-based studyThong, M. S. / Mols, F. / Lemmens, V. E. / Creemers, G. J. / Slooter, G. D. / van de Poll-Franse, L. V. et al. | 2011
- 1808
-
A U-shaped relationship between plasma folate and pancreatic cancer risk in the European Prospective Investigation into Cancer and NutritionChuang, S. C. / Stolzenberg-Solomon, R. / Ueland, P. M. / Vollset, S. E. / Midttun, O. / Olsen, A. / Tjonneland, A. / Overvad, K. / Boutron-Ruault, M. C. / Morois, S. et al. | 2011
- 1817
-
DNA methyltransferase 1 as a predictive biomarker and potential therapeutic target for chemotherapy in gastric cancerMutze, K. / Langer, R. / Schumacher, F. / Becker, K. / Ott, K. / Novotny, A. / Hapfelmeier, A. / Hofler, H. / Keller, G. et al. | 2011
- 1826
-
Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysisClarke, S. J. / Yip, S. / Brown, C. / van Hazel, G. A. / Ransom, D. T. / Goldstein, D. / Jeffrey, G. M. / Tebbutt, N. C. / Buck, M. / Lowenthal, R. M. et al. | 2011
- 1837
-
Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrenceBelt, E. J. / Fijneman, R. J. / van den Berg, E. G. / Bril, H. / Delis-van Diemen, P. M. / Tijssen, M. / van Essen, H. F. / de Lange-de Klerk, E. S. / Belien, J. A. / Stockmann, H. B. et al. | 2011
- 1846
-
Antiangiogenic agents and endothelin antagonists in advanced castration resistant prostate cancerMerino, M. / Pinto, A. / Gonzalez, R. / Espinosa, E. et al. | 2011
- 1852
-
Childhood cancer survival in Ireland: Temporal, regional and deprivation-related patternsWalsh, P. M. / Byrne, J. / Capra, M. / Comber, H. et al. | 2011
- 1863
-
A comprehensive study of psychometric properties of the Edmonton Symptom Assessment System (ESAS) in Spanish advanced cancer patientsCarvajal, A. / Centeno, C. / Watson, R. / Bruera, E. et al. | 2011
- 1873
-
Magnetic functionalised carbon nanotubes as drug vehicles for cancer lymph node metastasis treatmentYang, F. / Jin, C. / Yang, D. / Jiang, Y. / Li, J. / Di, Y. / Hu, J. / Wang, C. / Ni, Q. / Fu, D. et al. | 2011
- 1883
-
Cytokine analysis as a tool to understand tumour-host interaction in ovarian cancerYigit, R. / Figdor, C. G. / Zusterzeel, P. L. / Pots, J. M. / Torensma, R. / Massuger, L. F. et al. | 2011
- 1890
-
Seleno-cyclodextrin sensitises human breast cancer cells to TRAIL-induced apoptosis through DR5 induction and NF-kB suppressionLin, T. / Ding, Z. / Li, N. / Xu, J. / Luo, G. / Liu, J. / Shen, J. et al. | 2011
- 1908
-
IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGFBaird, A. M. / Gray, S. G. / O'Byrne, K. J. et al. | 2011
- 1919
-
Risk factors for metachronous contralateral breast cancer suggest two aetiological pathwaysVichapat, V. / Gillett, C. / Fentiman, I. S. / Tutt, A. / Holmberg, L. / Luchtenborg, M. et al. | 2011
- 1928
-
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studiesBen, Q. / Xu, M. / Ning, X. / Liu, J. / Hong, S. / Huang, W. / Zhang, H. / Li, Z. et al. | 2011
- 1938
-
Type I interferons as radiosensitisers for pancreatic cancerMorak, M. J. / van Koetsveld, P. M. / Kanaar, R. / Hofland, L. J. / van Eijck, C. H. et al. | 2011
- 1946
-
Differential gene expression signatures between colorectal cancers with and without KRAS mutations: Crosstalk between the KRAS pathway and other signalling pathwaysWatanabe, T. / Kobunai, T. / Yamamoto, Y. / Matsuda, K. / Ishihara, S. / Nozawa, K. / Iinuma, H. / Ikeuchi, H. / Eshima, K. et al. | 2011
- 1955
-
Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examinationKeizman, D. / Huang, P. / Eisenberger, M. A. / Pili, R. / Kim, J. J. / Antonarakis, E. S. / Hammers, H. / Carducci, M. A. et al. | 2011
- 1962
-
CYP1A1*2A polymorphism as a predictor of clinical outcome in advanced lung cancer patients treated with EGFR-TKI and its combined effects with EGFR intron 1 (CA)n polymorphismNie, Q. / Yang, X. n. / An, S. j. / Zhang, X. c. / Yang, J. j. / Zhong, W. z. / Liao, R. q. / Chen, Z. h. / Su, J. / Xie, Z. et al. | 2011
- 1971
-
Enhanced detection of BRAF-mutants by pre-PCR cleavage of wild-type sequences revealed circulating melanoma cells heterogeneityFusi, A. / Berdel, R. / Havemann, S. / Nonnenmacher, A. / Keilholz, U. et al. | 2011
- 1977
-
A first prospective population-based analysis investigating the actual practice of melanoma diagnosis, treatment and follow-upLivingstone, E. / Windemuth-Kieselbach, C. / Eigentler, T. K. / Rompel, R. / Trefzer, U. / Nashan, D. / Rotterdam, S. / Ugurel, S. / Schadendorf, D. et al. | 2011
- 1990
-
Prognostic value of the multidrug resistance transporter ABCG2 gene polymorphisms in Chinese patients with de novo acute leukaemiaWang, F. / Liang, Y. j. / Wu, X. p. / Chen, L. m. / To, K. K. / Dai, C. l. / Yan, Y. y. / Wang, Y. s. / Tong, X. z. / Fu, L. w. et al. | 2011
- 2000
-
The use of liposomal anthracycline analogues for childhood malignancies: A systematic reviewSieswerda, E. / Kremer, L. C. / Caron, H. N. / van Dalen, E. C. et al. | 2011
- 2009
-
The impact of short-term psycho-oncological interventions on the psychological outcome of cancer patients of a surgical-oncology department - A randomised controlled studyGoerling, U. / Foerg, A. / Sander, S. / Schramm, N. / Schlag, P. M. et al. | 2011
- 2015
-
Monocyte number associated with incident cancer and mortality in middle-aged and elderly community-dwelling DanesSajadieh, A. / Mouridsen, M. R. / Selmer, C. / Intzilakis, T. / Nielsen, O. W. / Haugaard, S. B. et al. | 2011
- 2023
-
Better survival in patients with metastasised kidney cancer after nephrectomy: A population-based study in the NetherlandsAben, K. K. / Heskamp, S. / Janssen-Heijnen, M. L. / Koldewijn, E. L. / van Herpen, C. M. / Kiemeney, L. A. / Oosterwijk, E. / van Spronsen, D. J. et al. | 2011
- 2033
-
Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons - the Swedish AMORIS studyVan Hemelrijck, M. / Jassem, W. / Walldius, G. / Fentiman, I. S. / Hammar, N. / Lambe, M. / Garmo, H. / Jungner, I. / Holmberg, L. et al. | 2011
- 2042
-
Apigenin affects leptin/leptin receptor pathway and induces cell apoptosis in lung adenocarcinoma cell lineBruno, A. / Siena, L. / Gerbino, S. / Ferraro, M. / Chanez, P. / Giammanco, M. / Gjomarkaj, M. / Pace, E. et al. | 2011
- 2052
-
Preclinical in vitro and in vivo evaluation of the potent and specific cyclin-dependent kinase 2 inhibitor NU6102 and a water soluble prodrug NU6301Thomas, H. D. / Wang, L. Z. / Roche, C. / Bentley, J. / Cheng, Y. / Hardcastle, I. R. / Golding, B. T. / Griffin, R. J. / Curtin, N. J. / Newell, D. R. et al. | 2011
- 2060
-
Suppression of retinoid X receptor alpha and aberrant b-catenin expression significantly associates with progression of colorectal carcinomaZhang, F. / Meng, F. / Li, H. / Dong, Y. / Yang, W. / Han, A. et al. | 2011
- 2068
-
Genetic and epigenetic control of UNC5C expression in human renal cell carcinomaLv, D. / Zhao, W. / Dong, D. / Qian, X. P. / Zhang, Y. / Tian, X. J. / Zhang, J. et al. | 2011
- 2077
-
The European Academy of Cancer Sciences| 2011
- 2082
-
What makes a good pathology report?Nobile, A. / Treboux, A. / Delaloye, J. F. / Zaman, K. / Jeanneret-Sozzi, W. / Schaefer, S. C. / Lehr, H. A. et al. | 2011
- 2084
-
Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patientsKong, X. / Moran, M. S. / Zhang, N. / Haffty, B. / Yang, Q. et al. | 2011
- 2091
-
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancerAmadori, D. / Milandri, C. / Comella, G. / Saracchini, S. / Salvagni, S. / Barone, C. / Bordonaro, R. / Gebbia, V. / Barbato, A. / Serra, P. et al. | 2011
- 2099
-
The role of ipsilateral breast radiotherapy in management of occult primary breast cancer presenting as axillary lymphadenopathyBarton, S. R. / Smith, I. E. / Kirby, A. M. / Ashley, S. / Walsh, G. / Parton, M. et al. | 2011
- 2107
-
Whole-body diffusion-weighted magnetic resonance imaging: Current evidence in oncology and potential role in colorectal cancer stagingLambregts, D. M. / Maas, M. / Cappendijk, V. C. / Prompers, L. M. / Mottaghy, F. M. / Beets, G. L. / Beets-Tan, R. G. et al. | 2011
- 2117
-
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinomaKudo, M. / Imanaka, K. / Chida, N. / Nakachi, K. / Tak, W. Y. / Takayama, T. / Yoon, J. H. / Hori, T. / Kumada, H. / Hayashi, N. et al. | 2011
- 2128
-
Oral disease and risk of oesophageal and gastric cancer in a nationwide nested case-control study in SwedenLjung, R. / Martin, L. / Lagergren, J. et al. | 2011
- 2133
-
Management of metastatic castration-resistant prostate cancer after first-line docetaxelHarrington, J. A. / Jones, R. J. et al. | 2011
- 2143
-
Re-evaluating the role of palliative radiotherapy in malignant pleural mesotheliomaJenkins, P. / Milliner, R. / Salmon, C. et al. | 2011
- 2150
-
New drugs in melanoma: It's a whole new worldEggermont, A. M. / Robert, C. et al. | 2011
- 2158
-
Laparoscopic hysterectomy is preferred over laparotomy in early endometrial cancer patients, however not cost effective in the very obeseBijen, C. B. / de Bock, G. H. / Vermeulen, K. M. / Arts, H. J. / ter Brugge, H. G. / van der Sijde, R. / Kraayenbrink, A. A. / Bongers, M. Y. / van der Zee, A. G. / Mourits, M. J. et al. | 2011
- 2166
-
Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 proteinLi, B. H. / Zhou, J. S. / Ye, F. / Cheng, X. D. / Zhou, C. Y. / Lu, W. G. / Xie, X. et al. | 2011
- 2175
-
Place of death and hospital care for children who died of cancer in England, 1999-2006Shah, A. / Diggens, N. / Stiller, C. / Murphy, D. / Passmore, J. / Murphy, M. F. et al. | 2011
- 2182
-
Factors affecting treatment choices in paediatric palliative care: Comparing parents and health professionalsTomlinson, D. / Bartels, U. / Hendershot, E. / Maloney, A. M. / Ethier, M. C. / Sung, L. et al. | 2011
- 2188
-
The Patient Reported Outcomes Following Initial treatment and Long term Evaluation of Survivorship registry: Scope, rationale and design of an infrastructure for the study of physical and psychosocial outcomes in cancer survivorship cohortsvan de Poll-Franse, L. V. / Horevoorts, N. / Eenbergen, M. v. / Denollet, J. / Roukema, J. A. / Aaronson, N. K. / Vingerhoets, A. / Coebergh, J. W. / de Vries, J. / Essink-Bot, M. L. et al. | 2011
- 2195
-
Psychiatric treatment in men with prostate cancer - Results from a Nation-wide, population-based cohort study from PCBaSe SwedenBill-Axelson, A. / Garmo, H. / Nyberg, U. / Lambe, M. / Bratt, O. / Stattin, P. / Adolfsson, J. / Steineck, G. et al. | 2011
- 2202
-
Choosing the relative survival method for cancer survival estimationHakulinen, T. / Seppa, K. / Lambert, P. C. et al. | 2011
- 2211
-
Levels of acute health service use among cancer survivors in the United KingdomMaddams, J. / Utley, M. / Moller, H. et al. | 2011
- 2221
-
Identification of a novel cell binding site of periostin involved in tumour growthOrecchia, P. / Conte, R. / Balza, E. / Castellani, P. / Borsi, L. / Zardi, L. / Mingari, M. C. / Carnemolla, B. et al. | 2011
- 2230
-
The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibodySaito, Y. / Hashimoto, Y. / Kuroda, J. i. / Yasunaga, M. / Koga, Y. / Takahashi, A. / Matsumura, Y. et al. | 2011
- 2240
-
Curcumin improves MMC-based chemotherapy by simultaneously sensitising cancer cells to MMC and reducing MMC-associated side-effectsZhou, Q. M. / Wang, X. F. / Liu, X. J. / Zhang, H. / Lu, Y. Y. / Huang, S. / Su, S. B. et al. | 2011
- 2249
-
Natural history, management and pharmacokinetics of Everolimus-induced-oral ulcers: Insights into compliance issuesFerte, C. / Paci, A. / Zizi, M. / Gonzales, D. B. / Goubar, A. / Gomez-Roca, C. / Massard, C. / Sahmoud, T. / Andre, F. / Soria, J. C. et al. | 2011
- 2256
-
Phase I, open-label, multicentre, dose-escalation, pharmacokinetic and pharmacodynamic trial of the oral aurora kinase inhibitor PF-03814735 in advanced solid tumoursSchoffski, P. / Jones, S. F. / Dumez, H. / Infante, J. R. / Van Mieghem, E. / Fowst, C. / Gerletti, P. / Xu, H. / Jakubczak, J. L. / English, P. A. et al. | 2011
- 2265
-
Determining circulating endothelial cells using CellSearch system during preoperative systemic chemotherapy in breast cancer patientsAli, A. M. / Ueno, T. / Tanaka, S. / Takada, M. / Ishiguro, H. / Abdellah, A. Z. / Toi, M. et al. | 2011
- 2273
-
Trastuzumab beyond progression: Overall survival analysis of the GBG 26/BIG 3-05 phase III study in HER2-positive breast cancervon Minckwitz, G. / Schwedler, K. / Schmidt, M. / Barinoff, J. / Mundhenke, C. / Cufer, T. / Maartense, E. / de Jongh, F. E. / Baumann, K. H. / Bischoff, J. et al. | 2011
- 2282
-
Hepatic resection for metastatic breast cancer: A systematic reviewChua, T. C. / Saxena, A. / Liauw, W. / Chu, F. / Morris, D. L. et al. | 2011
- 2291
-
Effectiveness and cost-effectiveness of peri-operative versus post-operative chemotherapy for resectable colorectal liver metastasesErcolani, G. / Cucchetti, A. / Cescon, M. / Peri, E. / Brandi, G. / Gaudio, M. D. / Ravaioli, M. / Zanello, M. / Pinna, A. D. et al. | 2011
- 2299
-
Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinomaNg, K. T. / Qi, X. / Kong, K. L. / Cheung, B. Y. / Lo, C. M. / Poon, R. T. / Fan, S. T. / Man, K. et al. | 2011
- 2306
-
Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer - A randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)Thuss-Patience, P. C. / Kretzschmar, A. / Bichev, D. / Deist, T. / Hinke, A. / Breithaupt, K. / Dogan, Y. / Gebauer, B. / Schumacher, G. / Reichardt, P. et al. | 2011
- 2315
-
Clinical management of primary vulvar cancerWoelber, L. / Kock, L. / Gieseking, F. / Petersen, C. / Trillsch, F. / Choschzick, M. / Jaenicke, F. / Mahner, S. et al. | 2011
- 2322
-
Randomised phase II study of amrubicin as single agent or in combination with cisplatin versus cisplatin etoposide as first-line treatment in patients with extensive stage small cell lung cancer - EORTC 08062O'Brien, M. E. / Konopa, K. / Lorigan, P. / Bosquee, L. / Marshall, E. / Bustin, F. / Margerit, S. / Fink, C. / Stigt, J. A. / Dingemans, A. M. et al. | 2011
- 2331
-
A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03)Gaafar, R. M. / Surmont, V. F. / Scagliotti, G. V. / Van Klaveren, R. J. / Papamichael, D. / Welch, J. J. / Hasan, B. / Torri, V. / van Meerbeeck, J. P. et al. | 2011
- 2341
-
Higher doses of opioids in patients who need palliative sedation prior to death: Cause or consequence?Oosten, A. W. / Oldenmenger, W. H. / van Zuylen, C. / Schmitz, P. I. / Bannink, M. / Lieverse, P. J. / Bromberg, J. E. / van der Rijt, C. C. et al. | 2011
- 2347
-
Pancreatoblastoma: A report from the European cooperative study group for paediatric rare tumours (EXPeRT)Bien, E. / Godzinski, J. / Dall'Igna, P. / Defachelles, A. S. / Stachowicz-Stencel, T. / Orbach, D. / Bisogno, G. / Cecchetto, G. / Warmann, S. / Ellerkamp, V. et al. | 2011
- 2353
-
RNAi-mediated silencing of VEGF-C inhibits non-small cell lung cancer progression by simultaneously down-regulating the CXCR4, CCR7, VEGFR-2 and VEGFR-3-dependent axes-induced ERK, p38 and AKT signalling pathwaysFeng, Y. / Hu, J. / Ma, J. / Feng, K. / Zhang, X. / Yang, S. / Wang, W. / Zhang, J. / Zhang, Y. et al. | 2011
- 2364
-
EGFR gene copy number alteration is a better prognostic indicator than protein overexpression in oral tongue squamous cell carcinomasNakata, Y. / Uzawa, N. / Takahashi, K. I. / Sumino, J. / Michikawa, C. / Sato, H. / Sonoda, I. / Ohyama, Y. / Okada, N. / Amagasa, T. et al. | 2011
- 2373
-
Corrigendum to "Tumour-mediated TRAIL-Receptor expression indicates effective apoptotic depletion of infiltrating CD8+ immune cells in clinical colorectal cancer" [European Journal of Cancer 46 (12) (2010) 2314-2323]Grimm, M. / Kim, M. / Rosenwald, A. / von Raden, B. H. / Tsaur, I. / Meier, E. / Heemann, U. / Germer, C. T. / Gasser, M. / Waaga-Gasser, A. M. et al. | 2011
- 2375
-
Avoiding the zero sum game in global cancer policy: Beyond 2011 UN high level summitSullivan, R. / Purushotham, A. D. et al. | 2011
- 2381
-
Early stopping rules in oncology: Considerations for cliniciansMukherjee, S. D. / Goffin, J. R. / Taylor, V. / Anderson, K. K. / Pond, G. R. et al. | 2011
- 2387
-
Efficacy and safety of bevacizumab in combination with docetaxel for the first-line treatment of elderly patients with locally recurrent or metastatic breast cancer: Results from AVADOPivot, X. / Schneeweiss, A. / Verma, S. / Thomssen, C. / Passos-Coelho, J. L. / Benedetti, G. / Ciruelos, E. / von Moos, R. / Chang, H. T. / Duenne, A. A. et al. | 2011
- 2396
-
Myotax: A phase II trial of docetaxel plus non-pegylated liposomal doxorubicin as first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclinesCurtit, E. / Nouyrigat, P. / Dohollou, N. / Levy, E. / Lortholary, A. / Gligorov, J. / Facchini, T. / Jaubert, D. / Maille, N. / Pivot, X. et al. | 2011
- 2403
-
Colorectal cancer in HIV positive individuals: The immunological effects of treatmentAlfa-Wali, M. / Tait, D. / Allen-Mersh, T. / Tekkis, P. / Nelson, M. / Stebbing, J. / Antoniou, A. / Bower, M. et al. | 2011
- 2408
-
Hospital volume and survival in oesophagectomy and gastrectomy for cancerAnderson, O. / Ni, Z. / Moller, H. / Coupland, V. H. / Davies, E. A. / Allum, W. H. / Hanna, G. B. et al. | 2011
- 2415
-
Swedish Lung Cancer Radiation Study Group: Predictive value of histology for radiotherapy response in patients with non-small cell lung cancerHolgersson, G. / Bergstrom, S. / Bergqvist, M. / Nyman, J. / Hoye, E. / Helsing, M. / Friesland, S. / Holgersson, M. / Birath, E. / Ekman, S. et al. | 2011
- 2422
-
Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: A meta-analysis of prospective studiesLarsson, S. C. / Wolk, A. et al. | 2011
- 2431
-
Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?Anninga, J. K. / Gelderblom, H. / Fiocco, M. / Kroep, J. R. / Taminiau, A. H. / Hogendoorn, P. C. / Egeler, R. M. et al. | 2011
- 2446
-
A prospective association between quality of life and risk for cancerFlensborg-Madsen, T. / Johansen, C. / Gronbaek, M. / Mortensen, E. L. et al. | 2011
- 2453
-
Systolic and diastolic dysfunction in long-term adult survivors of childhood cancerBrouwer, C. A. / Postma, A. / Vonk, J. M. / Zwart, N. / van den Berg, M. P. / Bink-Boelkens, M. T. / Dolsma, W. V. / Smit, A. J. / de Vries, E. G. / Tissing, W. J. et al. | 2011
- 2463
-
How to switch from morphine or oxycodone to methadone in cancer patients? A randomised clinical phase II trialMoksnes, K. / Dale, O. / Rosland, J. H. / Paulsen, O. / Klepstad, P. / Kaasa, S. et al. | 2011
- 2471
-
Death Receptor 5 and cellular FLICE-inhibitory protein regulate pemetrexed-induced apoptosis in human lung cancer cellsSu, L. / Liu, G. / Hao, X. / Zhong, N. / Zhong, D. / Liu, X. / Singhal, S. et al. | 2011
- 2479
-
MicroRNA-21 suppression impedes medulloblastoma cell migrationGrunder, E. / D'Ambrosio, R. / Fiaschetti, G. / Abela, L. / Arcaro, A. / Zuzak, T. / Ohgaki, H. / Lv, S. Q. / Shalaby, T. / Grotzer, M. et al. | 2011
- 2491
-
Removal notice to "Nimotuzumab in combination with docetaxel and carboplatin as treatment for advanced non-small-cell-lung-cancer" EJC Supp 9 (2011) 23Qi, D. / Wang, Q. / Huang, C. / Li, Y. / Yang, Y. / Cui, Y. / Xin, L. / Xu, J. / Wang, H. / Zheng, J. et al. | 2011
- 2493
-
Rare cancers are not so rare: The rare cancer burden in EuropeGatta, G. / van der Zwan, J. M. / Casali, P. G. / Siesling, S. / Dei Tos, A. P. / Kunkler, I. / Otter, R. / Licitra, L. / Mallone, S. / Tavilla, A. et al. | 2011
- 2512
-
Tumour growth rates and RECIST criteria in early drug developmentGomez-Roca, C. / Koscielny, S. / Ribrag, V. / Dromain, C. / Marzouk, I. / Bidault, F. / Bahleda, R. / Ferte, C. / Massard, C. / Soria, J. C. et al. | 2011
- 2517
-
The cost-effectiveness of adjuvant chemotherapy for early breast cancer: A comparison of no chemotherapy and first, second, and third generation regimens for patients with differing prognosesCampbell, H. E. / Epstein, D. / Bloomfield, D. / Griffin, S. / Manca, A. / Yarnold, J. / Bliss, J. / Johnson, L. / Earl, H. / Poole, C. et al. | 2011
- 2531
-
Incidental findings on brain Magnetic Resonance Imaging in long-term survivors of breast cancer treated with adjuvant chemotherapyKoppelmans, V. / Schagen, S. B. / Poels, M. M. / Boogerd, W. / Seynaeve, C. / Lugt, A. v. / Breteler, M. M. et al. | 2011
- 2537
-
Racial differences in acute toxicities of neoadjuvant or adjuvant chemotherapy in patients with early-stage breast cancerHan, H. S. / Reis, I. M. / Zhao, W. / Kuroi, K. / Toi, M. / Suzuki, E. / Syme, R. / Chow, L. / Yip, A. Y. / Gluck, S. et al. | 2011
- 2546
-
Meta-analysis of CHEK2 1100delC variant and colorectal cancer susceptibilityXiang, H. p. / Geng, X. p. / Ge, W. w. / Li, H. et al. | 2011
- 2552
-
miR-429 Modulates the expression of c-myc in human gastric carcinoma cellsSun, T. / Wang, C. / Xing, J. / Wu, D. et al. | 2011
- 2560
-
Influence of body mass index on outcome in advanced colorectal cancer patients receiving chemotherapy with or without targeted therapySimkens, L. H. / Koopman, M. / Mol, L. / Veldhuis, G. J. / Ten Bokkel Huinink, D. / Muller, E. W. / Derleyn, V. A. / Teerenstra, S. / Punt, C. J. et al. | 2011
- 2568
-
Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinomaChun, Y. H. / Kim, S. U. / Park, J. Y. / Kim, D. Y. / Han, K. H. / Chon, C. Y. / Kim, B. K. / Choi, G. H. / Kim, K. S. / Choi, J. S. et al. | 2011
- 2576
-
Angiogenesis: A prognostic determinant in pancreatic cancer?van der Zee, J. A. / van Eijck, C. H. / Hop, W. C. / van Dekken, H. / Dicheva, B. M. / Seynhaeve, A. L. / Koning, G. A. / Eggermont, A. M. / ten Hagen, T. L. et al. | 2011
- 2585
-
The pituitary-Leydig cell axis before and after orchiectomy in patients with stage I testicular cancerBandak, M. / Aksglaede, L. / Juul, A. / Rorth, M. / Daugaard, G. et al. | 2011
- 2592
-
Key predictive factors of axitinib (AG-013736)-induced proteinuria and efficacy: A phase II study in Japanese patients with cytokine-refractory metastatic renal cell CarcinomaTomita, Y. / Uemura, H. / Fujimoto, H. / Kanayama, H. o. / Shinohara, N. / Nakazawa, H. / Imai, K. / Umeyama, Y. / Ozono, S. / Naito, S. et al. | 2011
- 2603
-
Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatmentBecker, A. / Crombag, L. / Heideman, D. A. / Thunnissen, F. B. / van Wijk, A. W. / Postmus, P. E. / Smit, E. F. et al. | 2011
- 2607
-
Hormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysisGandini, S. / Iodice, S. / Koomen, E. / Pietro, A. D. / Sera, F. / Caini, S. et al. | 2011
- 2618
-
Genetic polymorphisms in DNA repair and oxidative stress pathways associated with malignant melanoma susceptibilityIbarrola-Villava, M. / Pena-Chilet, M. / Fernandez, L. P. / Aviles, J. A. / Mayor, M. / Martin-Gonzalez, M. / Gomez-Fernandez, C. / Casado, B. / Lazaro, P. / Lluch, A. et al. | 2011
- 2626
-
Estimating expected survival probabilities for relative survival analysis - Exploring the impact of including cancer patient mortality in the calculationsTalback, M. / Dickman, P. W. et al. | 2011
- 2633
-
A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyProctor, M. J. / Morrison, D. S. / Talwar, D. / Balmer, S. M. / Fletcher, C. D. / O'Reilly, D. S. / Foulis, A. K. / Horgan, P. G. / McMillan, D. C. et al. | 2011
- 2642
-
EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lungPark, C. Y. / Son, J. Y. / Jin, C. H. / Nam, J. S. / Kim, D. K. / Sheen, Y. Y. et al. | 2011
- 2654
-
Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathwayLi, W. / Chen, Z. / Gong, F. R. / Zong, Y. / Chen, K. / Li, D. M. / Yin, H. / Duan, W. M. / Miao, Y. / Tao, M. et al. | 2011
- 2665
-
Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments - A pilot studySharp, L. / Johansson, H. / Landin, Y. / Moegelin, I. M. / Bergenmar, M. et al. | 2011
- 2673
-
Sensitivity to previous irinotecan treatment does not predict the efficacy of combination chemotherapy with cetuximab plus irinotecan for wild-type KRAS metastatic colorectal cancerShitara, K. / Ura, T. / Matsuo, K. / Takahari, D. / Yokota, T. / Yuki, S. / Yoshida, M. / Utsunomiya, S. / Sato, Y. / Yamaura, H. et al. | 2011
- 2681
-
Modern insights into hepatic arterial infusion for liver metastases from colorectal cancerBouchahda, M. / Levi, F. / Adam, R. / Rougier, P. et al. | 2011
- 2691
-
Treatment with curative intent of stage III non-small cell lung cancer patients of 75years: A prospective population-based studyWanders, R. / Steevens, J. / Botterweck, A. / Dingemans, A. M. / Reymen, B. / Baardwijk, A. v. / Borger, J. / Bootsma, G. / Pitz, C. / Lunde, R. et al. | 2011
- 2698
-
False-positive screening results in the European randomized study of screening for prostate cancerKilpelainen, T. P. / Tammela, T. L. / Roobol, M. / Hugosson, J. / Ciatto, S. / Nelen, V. / Moss, S. / Maattanen, L. / Auvinen, A. et al. | 2011
- 2706
-
Phase 2 trial of linifanib (ABT-869) in patients with advanced renal cell cancer after sunitinib failureTannir, N. M. / Wong, Y. N. / Kollmannsberger, C. K. / Ernstoff, M. S. / Perry, D. J. / Appleman, L. J. / Posadas, E. M. / Cho, D. / Choueiri, T. K. / Coates, A. et al. | 2011
- 2715
-
Gene expression analysis of blastemal component reveals genes associated with relapse mechanism in Wilms tumourMaschietto, M. / Piccoli, F. S. / Costa, C. M. / Camargo, L. P. / Neves, J. I. / Grundy, P. E. / Brentani, H. / Soares, F. A. / Camargo, B. d. / Carraro, D. M. et al. | 2011
- 2723
-
Malignant peripheral nerve sheath tumours in NF1: Improved survival in women and in recent yearsIngham, S. / Huson, S. M. / Moran, A. / Wylie, J. / Leahy, M. / Evans, D. G. et al. | 2011
- 2729
-
Radiochemotherapy versus surgery plus radio(chemo)therapy for stage T3/T4 larynx and hypopharynx cancer - Results of a matched-pair analysisRades, D. / Schroeder, U. / Bajrovic, A. / Schild, S. E. et al. | 2011
- 2735
-
End of life care in adolescents and young adults with cancer: Experience of the adolescent unit of the Institut Gustave RoussyCohen-Gogo, S. / Marioni, G. / Laurent, S. / Gaspar, N. / Semeraro, M. / Gabolde, M. / Dufour, C. / Valteau-Couanet, D. / Brugieres, L. et al. | 2011
- 2742
-
The EORTC 10041/BIG 03-04 MINDACT trial is feasible: Results of the pilot phaseRutgers, E. / Piccart-Gebhart, M. J. / Bogaerts, J. / Delaloge, S. / Veer, L. V. / Rubio, I. T. / Viale, G. / Thompson, A. M. / Passalacqua, R. / Nitz, U. et al. | 2011
- 2750
-
New insights of mitochondria reactive oxygen species generation and cell apoptosis induced by low dose photodynamic therapyZhao, H. / Xing, D. / Chen, Q. et al. | 2011
- 2762
-
Referees 2011| 2011
- S1
-
SP 128 KRAS mutations in colorectal cancer: lessons learned and future progressEckhardt, S. G. et al. | 2011
- S2
-
SP 113 Translating molecular imaging agents into phase 3 trialsJacobs, P. et al. | 2011
- S3
-
4 EONS Distinguished Merit Award The Impact of a Maternal Cancer Diagnosis on School-age ChildrenFurlong, E. et al. | 2011
- S4
-
Chairpersons introductionJohnston, S. R. et al. | 2011
- S4
-
7 INVITED Possible Intervention Strategies to Reduce Radiation-induced Heart DiseaseHovinq, S. / Seemann, I. / Gabriels, K. / Visser, N. L. / te Poele, J. A. / Heeneman, S. / Daemen, M. J. / Stewart, F. A. et al. | 2011
- S5
-
14 INVITED Deregulated tRNA Expression in CancerWhite, R. J. et al. | 2011
- S6
-
18 INVITED Imaging of Hypoxia (HIF-1a) With Genetically Encoded Reporter GenesSerganova, I. / Blasberq, R. et al. | 2011
- S6
-
SP 112 Integration of metabolic imaging (PET CT) into clinical trialsWeber, W. et al. | 2011
- S6
-
The role of surgery in metastatic breast cancerRuiterkamp, J. / Ernst, M. F. et al. | 2011
- S7
-
21 INVITED The Epidemiology of Childhood Cancer SurvivorsHaupt, R. / Pisani, P. / Garwicz, S. / Hawkins, M. / Skinner, R. / Hjorth, L. et al. | 2011
- S8
-
OP 29 Development of a genomic-clinical classifier model for predicting clinical recurrence in patients with localized prostate cancerJenkins, R. / Crisan, A. / Erho, N. / Ballman, K. V. / Bergstralh, E. J. / Fink, S. R. / Kollmeyer, T. M. / Buerki, C. / Black, P. C. / Davicioni, E. et al. | 2011
- S9
-
29 INVITED Peritoneal Carcinomatosis of Colorectal OriginQuenet, F. / Escayola, C. / Viot, A. / Mehta, S. / Torrent, J. J. et al. | 2011
- S9
-
OP 75 An unbiased shRNA based lentiviral screen identifies tyrosine kinases that are important for survival and radioresistance in Head and Neck Squamous Cell CarcinomaVan Limbergen, E. J. / Zabrocki, P. / Porcu, M. / Hauben, E. / Cools, J. / Nuyts, S. et al. | 2011
- S11
-
38 INVITED Robotic Surgery - Opportunities and Issues for NursingMartin, S. et al. | 2011
- S11
-
PP 36 Highly-specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinomaBose, P. / McIntyre, J. B. / Klimowicz, A. C. / Brockton, N. T. / Petrilllo, S. / Matthews, W. / Easaw, J. / Magliocco, A. / Dort, J. C. et al. | 2011
- S12
-
PP 83 Gene expression profiling of circulating tumor cells in breast cancerCappelletti, V. / Fina, E. / Miodini, P. / Callari, M. / Musella, V. / Agresti, R. / Moliterni, A. / Daidone, M. G. et al. | 2011
- S12
-
42 INVITED Late Functional Outcome SurgeryDietz, A. et al. | 2011
- S13
-
PP 33 Detection of prostate cancer by plasma proteome profiling based on matrix-assisted laser desorption/ionization time-of-flight mass spectrometryChernyaev, V. / Shevchenko, V. E. / Arnotskaya, N. E. / Chernyaev, V. A. / Matveev, V. B. et al. | 2011
- S13
-
46 INVITED For Sentinel Node Positive Patients - is Complete Lymph Node Resection Still the Standard of Care?Nieweq, O. et al. | 2011
- S14
-
PP 4 Identification of specific biomarkers for glioma-initiating cells and glioma tumorsClement-Schatlo, V. / Tenan, M. / Schatlo, B. / Marino, D. / Burkhardt, K. / Schaller, K. / Radovanovic, I. et al. | 2011
- S16
-
PP 92 Clinical and genetic characterization of dihydropyrimidine dehydrogenase deficiency in fluoropyrimidine-treated patients carrying the DPYD2A alleleDel Re, M. / Barbara, C. / Loupakis, F. / Michelucci, A. / Simi, P. / Bocci, G. / Di Paolo, A. / Cappuzzo, F. / Falcone, A. / Danesi, R. et al. | 2011
- S17
-
PP 56 Suitability of advanced non-small cell lung cancer biopsies for prospective, multiple molecular analyses in clinical trialsFennell, D. / Nicolson, M. / Ferry, D. / OByrne, K. / Moore, S. / McErlean, S. / Kennedy, L. / Murray, N. / Das, M. / Kerr, K. et al. | 2011
- S17
-
65 INVITED Evidence to Support Definitive Chemo-RadiotherapyDe Ruvsscher, D. et al. | 2011
- S18
-
PP 63 Integrating hypoxia and native conditions for immune complex formation in the serological proteome analysis (SERPA) to improve the detection of autoantibodies as cancer biomarkersGrandjean, M. / Defresne, F. / Guilbaud, C. / Raes, M. / Dieu, M. / Sermeus, A. / De Ridder, M. / Feron, O. et al. | 2011
- S18
-
67 INVITED Stage III-N2 Non-Small Cell Lung Cancer - Choice of Chemotherapy SchemesFelip, E. et al. | 2011
- S19
-
PP 6 The metabolic response using FDG/PET for predicting tumor response and prognosis after pre-operative chemoradiotherapy (CRT) in patients with locally recurrent rectal cancer (LRRC)Ikeda, M. / Sekimoto, M. / Handa, R. / Nishimura, J. / Takemasa, I. / Mizushima, T. / Yamamoto, H. / Doki, Y. / Mori, M. et al. | 2011
- S20
-
PP 71 `Other' (non-activating, non-T790M) EGFR mutations and their clinical implications collected from various Tarceva trials in NSCLCKlughammer, B. / Spleiss, O. et al. | 2011
- S20
-
75 INVITED Differential and Unexpected Impact of Adjuvant Versus Metastatic Antiangiogenic TherapyKerbel, R. et al. | 2011
- S21
-
PP 10 Biomarker discovery by pharmacological studies in a population based tumor model for VEGFR inhibitorsLin, J. / Feng, J. / Bin, F. / Xiaojian, S. / Richard, N. / Brooke, E. / Slichenmyer, W. / Chiu, M. I. / Robinson, M. O. et al. | 2011
- S21
-
80 INVITED The Experience of Living With a PEGMartin, L. et al. | 2011
- S22
-
PP 11 Correlation between both serum osteopontin/osteonectin and bone remodelling parameters, inflammatory/metabolic variables and survival in metastatic cancer patients with tumors at different sitesMantovani, G. / Madeddu, C. / Astara, G. / Demurtas, L. / Antoni, G. / Serpe, R. / Ruggiero, V. et al. | 2011
- S22
-
86 INVITED Novel Designs and Alternate Endpoints for New Drug StudiesDittrich, C. et al. | 2011
- S23
-
PP 94 Polyamine Transport System (PTS) activity and hijacking in cancer cells: new option in Head and Neck tumors treatment with the polyamine-containing drug candidate F14512Meignan, S. / Mouawad, F. / Dewitte, A. / Bertheau, C. / Wattez, N. / Lartigau, E. / Chevalier, D. / Bailly, C. / Lansiaux, A. et al. | 2011
- S23
-
91 INVITED Update CTLA-4 Blockade Using Ipilimumab as First Line and Second Line Therapy for Advanced MelanomaWolchok, J. D. et al. | 2011
- S23
-
Radiotherapy in patients with metastatic breast cancerBudach, W. et al. | 2011
- S24
-
PP 57 Interaction of 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) with melanoma melanin metabolism and cell deathMorgan, L. / Benes, E. / Rodgers, A. / Jursic, B. / Struck, R. / Waud, W. / Weiner, R. / Ware, M. / Friedlander, P. et al. | 2011
- S25
-
101 INVITED Soft-tissue SarcomasChisholm, J. C. et al. | 2011
- S26
-
PP 41 Anticancer potential of Datura inoxia extract against cervical cancer HeLa cellsPandey, M. / Saraswati, S. et al. | 2011
- S27
-
110 INVITED Image-Guided Radiation Therapy - From Current Concept to Future PerspectivesJaffray, D. et al. | 2011
- S28
-
114 INVITED Translational Aspects of Hypoxia ModificationHoskin, P. J. et al. | 2011
- S28
-
Role of hormonal manipulations in patients with hormone-sensitive metastatic breast cancerBodmer, A. / Castiglione-Gertsch, M. et al. | 2011
- S28
-
PP 102 Gene expression profiles obtained from mouse hair, xenograft tumor and ex vivo human scalp hair to determine the effects of drug response following treatment with an EGFR inhibitorReed, B. / Grimes, E. / Mefo, T. / Harrison, E. / Meyer-Turkson, L. / Miele, G. / Brady, G. et al. | 2011
- S30
-
PP 60 Targeting hyaluronan in tumor stroma. Interim translational and biomarker evaluations of pegylated hyaluronidase (PEGPH20) in animal models and patients with advanced solid tumorsDychter, S. / Ramanathan, R. / Infante, J. / Rosen, L. / Von Hoff, D. / Shepard, M. / Jiang, P. / Maneval, D. / Selvam, P. / Frost, G. et al. | 2011
- S31
-
128 INVITED Melanoma Therapy - Realising the Potential in Targeted TherapyFlaherty, K. et al. | 2011
- S31
-
PP 76 Biomarker discovery using multiplexed in solution proximity extension assays: a case-control study for early detection of colorectal cancerThorsen, S. B. / Lundberg, M. / Assarsson, E. / Gee, N. / Nielsen, B. S. / Christensen, I. J. / Nielsen, H. J. / Brunner, N. / Stenvang, J. / Fredriksson, S. et al. | 2011
- S32
-
133 INVITED Diffuse Large Cell Lymphoma (DLCL)Rosenwald, A. et al. | 2011
- S32
-
PP 39 Multi-determinants analysis of molecular alterations as predictor of resistance to cetuximab in metastatic colorectal cancerUlivi, P. / Passardi, A. / Capelli, L. / Chiadini, E. / Bravaccini, S. / Valgiusti, M. / Scarpi, E. / Molinari, C. / Casadio, V. / Zoli, W. et al. | 2011
- S33
-
136 INVITED Quality Assurance Through Outcome Registration in Colorectal Cancer - an ECCO Initiative for Europevan de Velde, C. et al. | 2011
- S33
-
PP 30 Prospective comparison of Recurrence Score, uPA/PAI-1, central grade and molecular subtyping in early breast cancer: first results from the WSG-Plan B trial (interim analysis)Wuerstlein, R. / Gluz, O. / Kreipe, H. / Kates, R. / Degenhardt, T. / Liedtke, C. / Shak, S. / Nitz, U. / Harbeck, N. et al. | 2011
- S34
-
140 INVITED Clinical Proteomics in the Early Detection of Breast CancerCelis, J. et al. | 2011
- S36
-
149 INVITED Molecular Pathways in Radiation FibrosisVozenin-Brotons, M. et al. | 2011
- S37
-
153 INVITED How Radical Should Surgery Be?Mariette, C. / Piessen, G. et al. | 2011
- S37
-
Author index| 2011
- S38
-
157 INVITED Cross-over in Oncology Clinical Trials - Statistical IssuesSargent, D. et al. | 2011
- S38
-
The role of chemotherapy and targeted agents in patients with metastatic breast cancerJohnston, S. R. et al. | 2011
- S39
-
162 INVITED MR-response Criteria in NeurooncologyBendszus, M. et al. | 2011
- S40
-
167 INVITED Energy Balance Including Physical Activity Influence Breast and Colon Carcinogenesis - Results From Recent StudiesThune, I. et al. | 2011
- S41
-
172 INVITED `Spread of Excellence' (Dissemination) Activities of the European Network of Excellence for Cancer Research in Children and Adolescents (ENCCA)Pritchard-Jones, K. et al. | 2011
- S41
-
Disclosures| 2011
- S43
-
185 INVITED Eurocancoms Project - Multidisciplinary Guidelines Where are we?Schrijvers, D. et al. | 2011
- S44
-
188 INVITED Novel Molecular Targeted Agents in NSCLC (Beyond EGFR, ALK and IGFR1)Soria, J. C. et al. | 2011
- S45
-
193 INVITED A Future Research Agenda to Improve Pain Control Through Collaborative EffortsBuche, D. et al. | 2011
- S46
-
198 INVITED The Future of Radiation Therapy in Comprehensive Cancer CareJohansson, S. et al. | 2011
- S48
-
208 INVITED Radiation Oncology as a Clinical Specialty in a Multidisciplinary Environment: QUO VADIS?Perez, C. et al. | 2011
- S50
-
214 INVITED The EAU Guidelines on Testicular CancerLaquna, M. et al. | 2011
- S51
-
215 INVITED What is New in the Systemic Treatment of Urological Malignancies| 2011
- S51
-
216 INVITED Past Present and Future of Geriatric Oncology - a "Time Bomb"Audisio, R. et al. | 2011
- S52
-
219 INVITED Cancer Clinical Trials in the Elderly - Are we Ageist?Reed, M. et al. | 2011
- S52
-
Neoadjuvant chemotherapy for non-/resectable metastasesFolprecht, G. et al. | 2011
- S53
-
224 INVITED Age, Screening and High Risk Groups SurveillanceWilson, R. et al. | 2011
- S54
-
229 INVITED Tumour Suppressor Networks: Lessons From p53Oren, M. / Aylon, Y. / Shema, E. / Fuchs, G. et al. | 2011
- S55
-
235 INVITED Molecular Imaging for Response Monitoring in Esophageal CancerLordick, F. et al. | 2011
- S57
-
244 INVITED Prostate Cancer Patients - What do They Really Need?Denis, L. / Briers, E. / Boeye, F. / Van Daele, H. / Dourcy-Belle-Rose, B. / Costa, A. et al. | 2011
- S58
-
248 INVITED How to Reverse the Resistance to TrastuzumabAndre, F. / Campone, M. et al. | 2011
- S59
-
253 INVITED Tailored Adjuvant Chemotherapy According to Pathological Response (?)Scheithauer, W. et al. | 2011
- S61
-
264 INVITED Addressing Consequences of Treatment - the Role of RehabilitationRobb, K. et al. | 2011
- S61
-
Surgery of the primary in stage IV colorectal cancer with unresectable metastasesVerhoe, C. / de Wilt, J. H. / Burger, J. W. / Verheu, H. M. / Koopman, M. et al. | 2011
- S62
-
268 INVITED Personalised Therapy in Lung CancerRosell, R. et al. | 2011
- S63
-
272 INVITED Optimising Treatment in Gliomas - TranslationalBjerkviq, R. / Keunen, O. / Niclou, S. R. et al. | 2011
- S64
-
277 INVITED IGF1R Targeting in Non-sarcoma Pediatric MalignanciesGeoerqer, B. et al. | 2011
- S65
-
284 INVITED Active Surveillance| 2011
- S66
-
290 INVITED Surgical Resection of Hilar and Intrahematic CholangiocarcinomaFarges, O. et al. | 2011
- S67
-
297 INVITED Image-guided Adaptative Brachytherapy (IGABT) and External Radiotherapy in Patients With Cervix CancerHaie-Meder, C. / Mazeron, R. / Dumas, I. / Lhomme, C. / Morice, P. et al. | 2011
- S67
-
The treatment of patients with low tumour burden and/or slow growing diseaseMaughan, T. S. et al. | 2011
- S68
-
301 INVITED ALK in NSCLC - Paving the Way for Oncogene-directed TherapyDoebele, R. et al. | 2011
- S69
-
306 INVITED Surgical Management of Primary Retroperitoneal Sarcomas: Improving OutcomesStrauss, P. C. / Hayes, A. J. / Thomas, J. M. et al. | 2011
- S71
-
316 INVITED Breast Conservation in Young Women With Early Breast CancerVeronesi, U. et al. | 2011
- S72
-
319 INVITED Neoadjuvant Treatment in Colon CancerSobrero, A. / Di Benedetto, M. et al. | 2011
- S74
-
332 INVITED Registration-Directed Co-Development of Biomarkers and TherapeuticsBuller, R. / Sakul, H. / Wilner, K. / Selaru, N. / Taylor, I. / Ho, S. / Donnelly, E. et al. | 2011
- S76
-
Re-challenge and the concept of lines of therapy in metastatic colorectal cancerde Gramont, A. et al. | 2011
- S76
-
340 INVITED Who Needs a (new) Histopathological And/or Molecular Classification?Dei Tos, A. et al. | 2011
- S78
-
353 INVITED Immunotherapy of Paediatric MalignanciesMinard-Colin, V. / Valteau-Couanet, D. / Zitvogel, L. et al. | 2011
- S79
-
358 INVITED The Point of View of a StatisticianCollette, L. et al. | 2011
- S80
-
363 INVITED Non-compliance in the Adjutant Endocrine Treatment of Women With Breast CancerHadji, P. P. et al. | 2011
- S82
-
372 INVITED New Molecular Targeted TherapiesLloveL, J. et al. | 2011
- S83
-
378 INVITED New Directions in Angiogenesis TherapyJavson, G. C. et al. | 2011
- S84
-
385 INVITED The Role of BRAF and KRAS in Melanoma ProgressionMarais, R. et al. | 2011
- S86
-
395 INVITED How to Follow up the Acute and the Late Toxicity With New Emerging Therapies?Liao, Z. X. et al. | 2011
- S88
-
Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancerVergote, I. / Amant, F. / Kristensen, G. / Ehlen, T. / Reed, N. S. / Casado, A. et al. | 2011
- S88
-
402 INVITED Alternative Surgical Resections for Lobectomy| 2011
- S89
-
409 INVITED Dying Well - Challenges in Acute Oncology SettingsLarkin, P. et al. | 2011
- S90
-
414 INVITED Radiotherapy as Adjuvant Treatment to Surgery or as Definitive Treatment?Budach, V. et al. | 2011
- S93
-
First line therapy: have we made any improvement?Bookman, M. A. et al. | 2011
- S95
-
803 ORAL Analysis of Blood Plasma Factors in the AVITA Phase III Randomized Study of Bevacizumab (bev) With Gemcitabine-Erlotinib (GE) in Patients (pts) With Metastatic Pancreatic Cancer (mPC)Van Cutsem, E. / Jayson, G. / Dive, C. / Dilba, P. / de Haas, S. / Wild, N. / Delmar, P. / Scherer, S. J. et al. | 2011
- S97
-
1003 ORAL Crosstalk Between Homeobox Proteins and Polycomb Complexes in P16INK4a RegulationGil, J. / Popov, J. / Martin, N. / Raguz, S. / Li, S. / Walsh, M. et al. | 2011
- S98
-
1006 ORAL Prognostic Factors for Progression-free Survival (PFS), Overall Survival (OS), and Long-term OS (LT-OS) With Sunitinib in 1,059 Patients, Treated on Clinical Trials, With Metastatic Renal Cell Carcinoma (mRCC)Motzer, R. J. / Escudier, B. / Bukowski, R. / Rini, B. I. / Hutson, T. E. / Barrios, C. H. / Lin, X. / Fly, K. / Matczak, E. / Gore, M. E. et al. | 2011
- S99
-
1009 POSTER Mammary Gland Tumour Formation in Conditional Transgenic Mice Expressing GLI1Norum, J. H. / Kasper, M. / Jaks, V. / Toftgard, R. et al. | 2011
- S100
-
1012 POSTER Activation of Nuclear Factor Kappa B and Induction of Migrationinhibitory Factor in Tumours by Surgical Stress of Laparotomy Versus Carbon Dioxide Pneumoperitoneum in a Nude Mice ModelAmin, A. T. / Kitano, S. / Shiraishi, N. / Ninomiya, S. / Tajima, M. / Inomata, M. et al. | 2011
- S101
-
1016 POSTER Are CD133 Positive Cells From Esophagus Ascites Cancer Stem Cells?Stoeltinq, S. / Hinz, S. / Ungefroren, H. / Lehnert, H. / Gieseler, F. et al. | 2011
- S102
-
1020 POSTER Detection of Circulating Tumour Cells (CTCs) in Gastrointestinal Tumours Using Reverse Transcriptase-polymerase Chain Reaction (RT-PCR) MethodKucukyildirim, S. / Erdem, B. / Polat, Z. / Mergen, H. et al. | 2011
- S104
-
1028 POSTER Gabexate Mesilate Induces the Apoptosis of HepG2cellsOzeki, T. et al. | 2011
- S104
-
Clinical trials and decision-making strategies for optimal treatment of relapsed ovarian cancerLedermann, J. A. / Raja, F. A. et al. | 2011
- S105
-
1031 POSTER Protein-bound Polysaccharide From Phellinus Linteus Inhibits Tumour Growth, Invasion, and Angiogenesis Through Inhibition of Wnt/b-catenin Signaling in SW480 Human Colon Cancer CellsLim, K. / Song, K. S. / Li, G. / Kim, T. D. / Jing, K. / Seo, S. B. / Yoo, J. K. / Park, H. D. / Hwang, B. D. / Yoon, W. H. et al. | 2011
- S106
-
1035 POSTER Genome-wide Promoter and CpG Island DNA Methylation Screening Identifies Novel Prognostic Markers and Distinct Pathway in Rectal CancerLeonq, K. J. / Wei, W. / Tannahill, L. A. / Caldwell, G. M. / James, J. / Jones, C. E. / Morton, D. G. / Bach, S. R. / Matthews, G. M. et al. | 2011
- S108
-
1043 POSTER Lysyl TRNa Synthethase - Ap4a Pathway - a Possible Role in CancerNechushtan, H. / Schnall, G. / Razin, E. / Ofir-Birin, Y. / Ochayon, H. et al. | 2011
- S110
-
1050 POSTER Copy-neutral Loss of Heterozygosity at the P53 Locus in Esophageal Squamous Cell Carcinomas Associated With p53 MutationsSaeki, H. / Kitao, H. / Ando, K. / Egashira, A. / Oki, E. / Ohga, T. / Morita, M. / Emi, Y. / Kakeji, Y. / Maehara, Y. et al. | 2011
- S111
-
1054 POSTER 17beta-estradiol Signaling via Estrogen Receptor Alpha-36 Enhances Survival and Invasion of ERalpha-negative Breast Cancer CellsChaudhri, R. A. / Cuenca, N. / Hadadi, A. / Schwartz, Z. / Boyan, B. D. et al. | 2011
- S113
-
1061 POSTER Foxo3a Loss is a Key Event in High-grade Pelvic Serous CarcinogenesisLevanon, K. / Hirsch, M. / Miron, A. / Ligon, A. / Birrer, M. / Drapkin, R. et al. | 2011
- S114
-
1065 POSTER An in Vitro Comparative Study of Fulvestrant and Tamoxifen in Breast Cancer CellsGiannopoulou, E. / Lvmperatou, D. / Koutras, A. / Kalofonos, H. P. et al. | 2011
- S116
-
The role of targeted therapy in ovarian cancerBanerjee, S. / Kaye, S. et al. | 2011
- S116
-
1072 POSTER Silencing of DREV1 Promotes Cell Proliferation and Invasion in Lung AdenocarcinomaHarun, R. / Hazir, N. S. / Pang, J. C. / Rose, I. M. et al. | 2011
- S117
-
1076 POSTER Overexpression of Calreticulin in Malignant and Benign Breast Tumours: Relationship to the Humoral ImmunityEric-Nikolic, A. / Milovanovic, Z. / Sanchez, D. / Pekarikova, A. / Dzodic, R. / Matic, I. / Tuckova, L. / Jevric, M. / Buta, M. et al. | 2011
- S118
-
1079 POSTER Changes in Proteasome Pool in Human Papillary Thyroid Carcinoma DevelopmentKarpova, Y. / Astakhova, T. / Sharova, N. et al. | 2011
- S119
-
1083 POSTER The Effects of Heparan Sulfate Mimetic RGTA-OTR4120 on Radiation-induced Salivary Gland Dysfunction in MiceSpieqelberq, L. / Djasim, U. M. / van Neck, J. W. / Wolvius, E. B. / van der Wal, K. G. et al. | 2011
- S120
-
1087 POSTER The Synergic Effect of CKD-516 to Conventional ChemotherapyKim, S. / Yoon, S. A. / Lee, D. H. / Shin, H. J. / Lim, I. T. / Yu, H. S. / Kim, D. H. / Kim, S. K. / Lee, S. S. et al. | 2011
- S122
-
1094 POSTER EpCAM+ Tumour Cells Are Frequently Detected in Malignant Ascites Samples- Results From a Randomized Phase 1Mb CASIMas StudyMartinius, H. / Biesterfeld, S. / Seitz-Merwald, I. / Hennig, M. / Seimetz, D. / Booking, A. et al. | 2011
- S124
-
1101 POSTER Identification of KRas Mutational Polymorphism by Molecular Analysis Using High-resolution Melting System in a Large MCRC Mexican SampleVega, H. A. / Romero-Garcia, P. / Silva, J. A. / Villalobos-Valencia, R. / Vazquez-Rivera, V. M. / Ruiz-Calzada, H. / Lopez-Yafiez, A. / Cortes-Esteban, P. / Calderillo-Ruiz, G. / Ruiz-Garcia, E. et al. | 2011
- S126
-
1108 POSTER DEAD/H (Asp-Glu-Ala-Asp/His) Box Polypeptide 3, X-linked is a CD133+ Tumour-specific Protein and Induces Antitumour ImmunityIchikawa, K. / Kagamu, H. / Koshio, J. / Saida, Y. / Miura, S. / Watanabe, S. / Tanaka, J. / Yoshizawa, H. / Narita, I. et al. | 2011
- S127
-
1111 POSTER Adoptive T Cell Therapy Enhances the Secretion Ability of Cytokines to Th1 and Reduces the Number of TregsSakamoto, N. / Kokura, S. / Ishikawa, T. / Matsumoto, T. / Uno, K. / Naito, Y. / Yoshikawa, T. et al. | 2011
- S128
-
1115 POSTER Impaired Autophagy Contributes to Resistance to Metronomic Cyclophosphamide ChemotherapyChow, A. / Emmeneqqer, U. et al. | 2011
- S129
-
1119 POSTER Influence of Soluble CD40 Ligand on Colorectal Cancer Cells: a Flow Cytometric StudyTorchio, M. / Comolli, G. / Chiesa, A. / Mazzini, G. / Danova, M. et al. | 2011